Masatoshi Kudo
#66,099
Most Influential Person Now
Researcher
Masatoshi Kudo's AcademicInfluence.com Rankings
Masatoshi Kudocomputer-science Degrees
Computer Science
#2181
World Rank
#2269
Historical Rank
Machine Learning
#111
World Rank
#112
Historical Rank
Database
#193
World Rank
#200
Historical Rank
Artificial Intelligence
#206
World Rank
#210
Historical Rank
Download Badge
Computer Science
Masatoshi Kudo's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Masatoshi Kudo Influential?
(Suggest an Edit or Addition)Masatoshi Kudo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial (2017) (2764)
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial (2018) (2744)
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial (2017) (2452)
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. (2020) (2450)
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. (2018) (1462)
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017) (1338)
- Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. (2013) (1082)
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010) (1013)
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. (2019) (969)
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial. (2019) (861)
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version (2011) (749)
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia (2009) (730)
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015) (706)
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. (2015) (697)
- Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial. (2013) (652)
- Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study. (2013) (649)
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 1: basic principles and terminology. (2015) (649)
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) (2003) (640)
- Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. (2015) (639)
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015) (563)
- CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) (2019) (535)
- Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. (2013) (522)
- JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan (2014) (515)
- Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial. (2014) (513)
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. (2011) (485)
- Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial. (2015) (478)
- Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma (2020) (461)
- Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib (2020) (433)
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC (2021) (402)
- Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan † (2007) (398)
- Evidence‐based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH‐HCC Guidelines) (2015) (368)
- Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score (2004) (341)
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2012 (2012) (336)
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 2: breast. (2015) (332)
- Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update (2019) (320)
- Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. (2008) (315)
- Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. (2013) (314)
- Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial (2019) (298)
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. (2016) (297)
- Characterization of Small Solid Tumors in the Pancreas: The Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography (2012) (290)
- Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations. (2018) (271)
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. (2018) (268)
- The role of hepatic resection in the treatment of hepatocellular cancer (2015) (266)
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology (2007) (256)
- Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma (2016) (255)
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial (2014) (250)
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. (2017) (248)
- Consensus on extra‐hepatic portal vein obstruction (2006) (247)
- Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study. (2016) (246)
- Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. (2020) (238)
- Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography (2004) (238)
- Prospective comparative study of the EUS guided 25‐gauge FNA needle with the 19‐gauge Trucut needle and 22‐gauge FNA needle in patients with solid pancreatic masses (2009) (232)
- Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. (2021) (230)
- Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma. (2021) (228)
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma (2019) (214)
- The committee for revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma (2010) (212)
- Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. (2020) (209)
- GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis (2013) (205)
- How to perform Contrast-Enhanced Ultrasound (CEUS) (2018) (200)
- Multistep human hepatocarcinogenesis: correlation of imaging with pathology (2009) (196)
- General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan (2015) (194)
- Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update (2014) (189)
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040. (2019) (187)
- Surveillance, Diagnosis, Treatment, and Outcome of Liver Cancer in Japan (2015) (187)
- Estimation of Liver Function Using T1 Mapping on Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging (2011) (186)
- A novel perfusion imaging technique of the pancreas: contrast-enhanced harmonic EUS (with video). (2008) (181)
- Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. (2012) (177)
- IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC). (2021) (172)
- Signaling Pathways Governing Tumor Angiogenesis (2011) (170)
- Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. (2018) (170)
- Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC). (2019) (170)
- Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma (2015) (167)
- Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. (2009) (167)
- Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference (2020) (164)
- Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function (2017) (162)
- Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009) (2010) (162)
- IMbrave150: Efficacy and safety results from a ph III study evaluating atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (Sor) as first treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC) (2019) (160)
- Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study (2019) (156)
- Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. (2017) (156)
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update (2021) (154)
- Utility of contrast-enhanced endoscopic ultrasonography for diagnosis of small pancreatic carcinomas. (2008) (153)
- Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan (2010) (150)
- Computer-Aided Diagnosis Based on Convolutional Neural Network System for Colorectal Polyp Classification: Preliminary Experience (2017) (149)
- Radiofrequency Ablation for Hepatocellular Carcinoma: Updated Review in 2010 (2010) (148)
- Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis. (2019) (146)
- Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials (2017) (145)
- Differential Diagnosis of Hepatic Tumors: Value of Contrast-Enhanced Harmonic Sonography Using the Newly Developed Contrast Agent, Sonazoid (2008) (143)
- FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma (2013) (143)
- Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria) (2015) (141)
- Prognostic Impact of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma: An Analysis of 1160 Cases From a Nationwide Survey (2014) (139)
- Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma (2012) (138)
- Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. (2001) (136)
- Report of the 18th follow‐up survey of primary liver cancer in Japan (2010) (136)
- Diagnostic Accuracy of Imaging for Liver Cirrhosis Compared to Histologically Proven Liver Cirrhosis (2008) (135)
- Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin‐reactive α‐fetoprotein 1 (2001) (134)
- Systemic Therapy for Hepatocellular Carcinoma: Latest Advances (2018) (134)
- Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications (2017) (133)
- Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA. (2022) (130)
- The challenge of prognosis and staging for hepatocellular carcinoma. (2010) (130)
- Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version) (2010) (126)
- Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis (2019) (124)
- Phase III trial of sunitinib (Su) versus sorafenib (So) in advanced hepatocellular carcinoma (HCC). (2011) (123)
- A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. (2015) (123)
- A phase 1b trial of lenvatinib (LEN) plus pembrolizumab (PEM) in patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2018) (123)
- Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study (2021) (122)
- Report of the 19th follow‐up survey of primary liver cancer in Japan (2016) (122)
- Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. (2012) (120)
- Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma (2011) (120)
- Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan (2015) (119)
- Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors. (1992) (119)
- Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan (2013) (118)
- Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond (2019) (118)
- Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey (2017) (115)
- Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis (2018) (115)
- Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions. (1999) (115)
- Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. (1992) (113)
- Consensus report of the 2nd International Forum for Liver MRI (2009) (111)
- First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non‐interventional study (2012) (110)
- Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond. (2018) (110)
- Noninvasive Evaluation of Hepatic Fibrosis Using Serum Fibrotic Markers, Transient Elastography (FibroScan) and Real-Time Tissue Elastography (2008) (110)
- Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer (2017) (110)
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements (2020) (109)
- The 2008 Okuda lecture: Management of hepatocellular carcinoma: From surveillance to molecular targeted therapy (2010) (109)
- Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver – Update 2020 – WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS (2020) (108)
- Immunopathogenesis of pancreatitis (2016) (107)
- Imaging findings of biliary hamartomas. (2005) (107)
- Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 Patients (2007) (107)
- Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. (2008) (106)
- Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. (2003) (106)
- Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms (2013) (105)
- TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. (2016) (105)
- Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan (2016) (105)
- Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio. (2004) (104)
- Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial (2016) (102)
- Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis (2017) (102)
- Treatment of Advanced Hepatocellular Carcinoma with Emphasis on Hepatic Arterial Infusion Chemotherapy and Molecular Targeted Therapy (2012) (101)
- Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan (2020) (101)
- Effect of vitamin K2 on the recurrence of hepatocellular carcinoma (2011) (101)
- Systemic Therapy for Hepatocellular Carcinoma: 2017 Update (2017) (100)
- Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study (2019) (100)
- Sonazoid-Enhanced Ultrasonography for Diagnosis of Hepatic Malignancies: Comparison with Contrast-Enhanced CT (2008) (100)
- REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset (2019) (99)
- Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan (2010) (98)
- Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study. (2018) (98)
- Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos). (2011) (97)
- Radiofrequency ablation of hepatocellular carcinoma: Current status. (2010) (97)
- Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma (2012) (97)
- Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. (2013) (96)
- Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma (2022) (96)
- Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. (2010) (95)
- Toll-like receptor activation in basophils contributes to the development of IgG4-related disease (2013) (94)
- Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC. (2008) (93)
- Hepatocellular Carcinoma: Therapeutic Guidelines and Medical Treatment (2016) (93)
- Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers. (2006) (92)
- 1398 BRIVANIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) WHO FAILED OR WERE INTOLERANT TO SORAFENIB: RESULTS FROM THE PHASE 3 BRISK-PS STUDY (2012) (92)
- Identification and characterization of IgG4‐associated autoimmune hepatitis (2010) (92)
- REACH-2: A randomized, double-blind, placebo-controlled phase 3 study of ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP) following first-line sorafenib. (2018) (92)
- Local ablation therapy for hepatocellular carcinoma: current status and future perspectives (2004) (91)
- Lenvatinib (len) plus pembrolizumab (pembro) for the first-line treatment of patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 3 LEAP-002 study. (2019) (91)
- EUS-Guided Broad Plexus Neurolysis Over the Superior Mesenteric Artery Using a 25-Gauge Needle (2010) (90)
- Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma (2020) (89)
- Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review (2011) (88)
- Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy (2008) (88)
- Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update (2017) (86)
- Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. (2001) (86)
- Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. (2009) (86)
- JSUM ultrasound elastography practice guidelines: liver (2013) (86)
- Endoscopic band ligation for control of nonvariceal upper GI hemorrhage: comparison with bipolar electrocoagulation. (2002) (85)
- Recurrence‐free survival more than 10 years after liver resection for hepatocellular carcinoma (2011) (85)
- Non-Invasive Evaluation of Hepatic Fibrosis for Type C Chronic Hepatitis (2010) (85)
- Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma (2010) (84)
- Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe (2015) (84)
- Quantitative assessment of hepatocellular function through in vivo radioreceptor imaging with technetium 99m galactosyl human serum albumin (1993) (83)
- Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication (2016) (83)
- Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial. (2021) (83)
- Novel Image Analysis Method Using Ultrasound Elastography for Noninvasive Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis C (2013) (83)
- Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status. (2019) (83)
- High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan (1999) (83)
- Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma (2010) (83)
- Phase III trial of linifanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC). (2013) (82)
- First attempt of boron neutron capture therapy (BNCT) for hepatocellular carcinoma. (2007) (82)
- Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. (2007) (82)
- Phase III trial of lenvatinib (LEN) vs sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2017) (82)
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma. (2016) (82)
- Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis. (2012) (82)
- Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC). (2020) (81)
- Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA (1999) (80)
- Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma. (2015) (80)
- IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation. (2020) (80)
- Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma (2018) (80)
- Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures (2019) (79)
- Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts (2015) (79)
- Hepatocellular carcinoma: depiction of tumor parenchymal flow with intermittent harmonic power Doppler US during the early arterial phase in dual-display mode. (2001) (79)
- Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. (1992) (78)
- Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score (2017) (78)
- Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT (2012) (76)
- Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles. (1991) (76)
- CheckMate 040 Cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis. (2021) (76)
- Surveillance and Diagnostic Algorithm for Hepatocellular Carcinoma Proposed by the Liver Cancer Study Group of Japan: 2014 Update (2014) (76)
- Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study. (2017) (76)
- RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. (2019) (76)
- Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy (2007) (76)
- Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. (2004) (75)
- Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach (2019) (75)
- Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma (2015) (74)
- EUS-guided gallbladder drainage for rescue treatment of malignant distal biliary obstruction after unsuccessful ERCP. (2016) (74)
- Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer (2020) (74)
- Assessment of Liver Fibrosis with Real-Time Tissue Elastography in Chronic Viral Hepatitis (2013) (73)
- Reactive Oxygen Species Induce Epigenetic Instability through the Formation of 8-Hydroxydeoxyguanosine in Human Hepatocarcinogenesis (2013) (73)
- Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study (2014) (72)
- A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE (2019) (72)
- Intrahepatic portosystemic venous shunt: diagnosis by color Doppler imaging. (1993) (72)
- Liver Cancer Working Group report. (2010) (72)
- Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: A Literature Review (2012) (71)
- Randomized, open‐label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma (2016) (71)
- Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. (2003) (70)
- Re‐evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel (2014) (70)
- Percutaneous ultrasound-guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome (2003) (70)
- Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis (2013) (69)
- Needle Tract Seeding: An Overlooked Rare Complication of Endoscopic Ultrasound-Guided Fine-Needle Aspiration (2017) (69)
- Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis. (2018) (68)
- Will Gd-EOB-MRI Change the Diagnostic Algorithm in Hepatocellular Carcinoma? (2010) (67)
- Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer. (2015) (67)
- Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm. (2010) (67)
- Histologic diagnosis of pancreatic masses using 25-gauge endoscopic ultrasound needles with and without a core trap: a multicenter randomized trial (2016) (66)
- Japan’s Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance (2012) (66)
- Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update (2018) (66)
- Locoregional Therapy for Hepatocellular Carcinoma (2015) (66)
- Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients (2018) (65)
- Sorafenib: key lessons from over 10 years of experience (2019) (65)
- Regulatory failure of serum prohepcidin levels in patients with hepatitis C. (2006) (65)
- Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation (2007) (64)
- Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study (2010) (64)
- Contrast‐enhanced endoscopic ultrasound (2014) (64)
- Epidemiology of Hepatocellular Carcinoma in Japan and Korea (2008) (63)
- p38α inhibits liver fibrogenesis and consequent hepatocarcinogenesis by curtailing accumulation of reactive oxygen species. (2013) (63)
- Response Evaluation of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas: The Usefulness of Sonazoid-Enhanced Harmonic Sonography (2008) (62)
- Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. (2014) (62)
- Early Hepatocellular Carcinoma: Definition and Diagnosis (2013) (62)
- Magnifying Narrow Band Imaging (NBI) for the Diagnosis of Localized Colorectal Lesions Using the Japan NBI Expert Team (JNET) Classification (2017) (62)
- A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results (2019) (61)
- Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma (2019) (61)
- Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score (2008) (61)
- Plasmacytoid Dendritic Cell Activation and IFN-α Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis (2015) (61)
- Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI (2015) (61)
- Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. (2004) (61)
- Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer. (2014) (61)
- A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation (2018) (61)
- Nationwide Study of 4741 Patients With Non-B Non-C Hepatocellular Carcinoma With Special Reference to the Therapeutic Impact (2014) (60)
- Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study. (2017) (60)
- Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma (2013) (59)
- First-line avelumab + axitinib in patients with advanced hepatocellular carcinoma: Results from a phase 1b trial (VEGF Liver 100). (2019) (59)
- Diagnostic Imaging of Hepatocellular Carcinoma: Recent Progress (2011) (59)
- Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma. (2011) (58)
- STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) (2014) (58)
- Real Practice of Hepatocellular Carcinoma in Japan: Conclusions of the Japan Society of Hepatology 2009 Kobe Congress (2010) (58)
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC) (2013) (58)
- Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update (2016) (56)
- Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma (2007) (56)
- LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC) (2022) (56)
- Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma (2017) (56)
- NOD2 Down-Regulates Colonic Inflammation by IRF4-Mediated Inhibition of K63-Linked Polyubiquitination of RICK and TRAF6 (2014) (55)
- Immune Checkpoint Blockade in Hepatocellular Carcinoma (2015) (55)
- Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma (2011) (54)
- Endoscopic Ultrasonography-Guided Biliary Drainage: Evaluation of a Choledochoduodenostomy Technique (2011) (54)
- Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation. (2017) (54)
- Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography (2014) (54)
- Value of contrast‐enhanced harmonic endoscopic ultrasonography with enhancement pattern for diagnosis of pancreatic cancer: A meta‐analysis (2019) (53)
- Diagnosis of subepithelial tumors in the upper gastrointestinal tract by endoscopic ultrasonography. (2010) (53)
- Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. (1998) (53)
- Serum proinflammatory cytokines and adhesion molecules in ulcerative colitis. (2006) (53)
- Immune checkpoint blockade for the treatment of human hepatocellular carcinoma (2018) (53)
- Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-α and IL-33 Produced by Plasmacytoid Dendritic Cells (2017) (53)
- Diagnosis of gallbladder diseases by contrast-enhanced phase-inversion harmonic ultrasonography. (2007) (53)
- Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma (2019) (52)
- Distinction between hemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPECT scanning. (1989) (52)
- Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey (2017) (52)
- Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan (2019) (52)
- Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method (2018) (52)
- Molecular Link between Liver Fibrosis and Hepatocellular Carcinoma (2013) (52)
- Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma (2011) (50)
- Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience. (2009) (50)
- Low-Dose, Long-Term, Intermittent Interferon-alpha-2b Therapy after Radical Treatment by Radiofrequency Ablation Delays Clinical Recurrence in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma (2005) (50)
- Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2. (2010) (50)
- Combination Cancer Immunotherapy in Hepatocellular Carcinoma (2018) (50)
- A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117. (2020) (50)
- The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid (2020) (49)
- New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma (2007) (49)
- S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial. (2017) (49)
- Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience (2010) (49)
- NEW TECHNIQUES AND FUTURE PERSPECTIVE OF EUS FOR THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC MALIGNANCIES: CONTRAST HARMONIC IMAGING (2011) (49)
- LBA-03Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial (2016) (49)
- Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm (2013) (49)
- Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score (2008) (49)
- A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC). (2020) (49)
- Extremely High Objective Response Rate of Lenvatinib: Its Clinical Relevance and Changing the Treatment Paradigm in Hepatocellular Carcinoma (2018) (48)
- Transarterial Chemoembolization in Combination with a Molecular Targeted Agent: Lessons Learned from Negative Trials (Post-TACE, BRISK-TA, SPACE, ORIENTAL, and TACE-2) (2017) (48)
- Validation of the hepatoma arterial embolization prognostic score in European and Asian populations and proposed modification. (2015) (48)
- MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma (2016) (48)
- Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic era. The views of a panel of worldwide international experts (2020) (47)
- Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis: Long-term outcomes after removal of a self-expandable metal stent (2017) (47)
- Clinical Characteristics of NonBNonC- HCC: Comparison with HBV and HCV Related HCC (2006) (47)
- On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study (2017) (47)
- Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials (2019) (46)
- Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey. (2020) (46)
- Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: A multicentre study (1997) (46)
- Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction. (2013) (46)
- Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib (2018) (46)
- Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study (2022) (46)
- Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update (2012) (46)
- Signaling pathway/molecular targets and new targeted agents under development in hepatocellular carcinoma. (2012) (46)
- Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study (2016) (45)
- Imaging Blood Flow Characteristics of Hepatocellular Carcinoma (2002) (45)
- Antibody to Hepatitis B Core Antigen and Risk for Hepatitis CRelated Hepatocellular Carcinoma (2007) (45)
- Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (2020) (45)
- Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma (2011) (45)
- Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (NIVO) in patients with advanced hepatocellular carcinoma (aHCC): Subanalyses of CheckMate-040. (2018) (45)
- Management of Hepatocellular Carcinoma in Japan as a World-Leading Model (2017) (45)
- Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey (2014) (45)
- Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy (2014) (45)
- [Phase III multi-center clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. (1992) (44)
- Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report (2011) (44)
- Analysis of survival and objective response (OR) in patients with hepatocellular carcinoma in a phase III study of lenvatinib (REFLECT). (2019) (44)
- Comparison of the efficacy and safety of endoscopic ultrasound‐guided choledochoduodenostomy and hepaticogastrostomy for malignant distal biliary obstruction: Multicenter, randomized, clinical trial (2019) (44)
- Validation of the Criteria of Transcatheter Arterial Chemoembolization Failure or Refractoriness in Patients with Advanced Hepatocellular Carcinoma Proposed by the LCSGJ (2014) (44)
- Characterization of intra-abdominal lesions of undetermined origin by contrast-enhanced harmonic EUS (with videos). (2010) (44)
- Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma (2015) (43)
- Oral Branched-Chain Amino Acid Granules Reduce the Incidence of Hepatocellular Carcinoma and Improve Event-Free Survival in Patients with Liver Cirrhosis (2011) (43)
- Cold-inducible RNA-binding protein promotes the development of liver cancer (2015) (43)
- Morphological diagnosis of hepatocellular carcinoma: special emphasis on intranodular hemodynamic imaging. (1998) (43)
- Regorafenib as Second-Line Systemic Therapy May Change the Treatment Strategy and Management Paradigm for Hepatocellular Carcinoma (2016) (43)
- A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib (2017) (43)
- Combination Guidance of Contrast-Enhanced US and Fusion Imaging in Radiofrequency Ablation for Hepatocellular Carcinoma with Poor Conspicuity on Contrast-Enhanced US/Fusion Imaging (2014) (43)
- Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) (2016) (42)
- Safety and efficacy of tigatuzumab plus sorafenib as first-line therapy in subjects with advanced hepatocellular carcinoma: A phase 2 randomized study. (2015) (42)
- Combination Cancer Immunotherapy with Molecular Targeted Agents/Anti-CTLA-4 Antibody for Hepatocellular Carcinoma (2019) (42)
- Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009) (2010) (42)
- Lenvatinib in Advanced Hepatocellular Carcinoma (2017) (41)
- Signaling Pathway and Molecular-Targeted Therapy for Hepatocellular Carcinoma (2011) (41)
- KEYNOTE-240: Randomized phase III study of pembrolizumab versus best supportive care for second-line advanced hepatocellular carcinoma. (2017) (41)
- Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein. (2019) (41)
- Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis (2016) (41)
- Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) second interim analysis in more than 1,500 patients: Clinical findings in patients with liver dysfunction. (2011) (41)
- Safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): Interim analysis of dose-expansion cohorts from the phase 1/2 CheckMate-040 study. (2016) (40)
- Sonazoid-enhanced Ultrasound in the Diagnosis and Treatment of Hepatic Tumors (2008) (40)
- Early detection and curative treatment of early-stage hepatocellular carcinoma. (2005) (40)
- Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON (2016) (40)
- Hepatic malignancies: Correlation between sonographic findings and pathological features. (2010) (40)
- Removal of diminutive colorectal polyps: A prospective randomized clinical trial between cold snare polypectomy and hot forceps biopsy (2017) (40)
- Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease. (2018) (40)
- Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort. (2019) (40)
- EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib. (2014) (40)
- Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid (2008) (39)
- A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score (2008) (39)
- Impacts of COVID-19 on Liver Cancers: During and after the Pandemic (2020) (39)
- Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonics US (2005) (39)
- Unique features associated with hepatic oxidative DNA damage and DNA methylation in non‐alcoholic fatty liver disease (2016) (39)
- Hypovascular Hepatic Nodules Showing Hypointense on the Hepatobiliary-Phase Image of Gd-EOB-DTPA-Enhanced MRI to Develop a Hypervascular Hepatocellular Carcinoma: A Nationwide Retrospective Study on Their Natural Course and Risk Factors (2013) (38)
- B-Mode Ultrasonography versus Contrast-Enhanced Ultrasonography for Surveillance of Hepatocellular Carcinoma: A Prospective Multicenter Randomized Controlled Trial (2019) (38)
- Usefulness of Combination of Imaging Modalities in the Diagnosis of Hepatocellular Carcinoma Using Sonazoid®-Enhanced Ultrasound, Gadolinium Diethylene-Triamine-Pentaacetic Acid-Enhanced Magnetic Resonance Imaging, and Contrast-Enhanced Computed Tomography (2011) (38)
- Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial. (2018) (38)
- Primary Intracranial Malignant Schwannoma of Trigeminal Nerve. A Case Report with Review of the Literature (2000) (38)
- Usefulness of Contrast-Enhanced Ultrasonography to Evaluate the Post-Treatment Responses of Radiofrequency Ablation for Hepatocellular Carcinoma: Comparison with Dynamic CT (2013) (38)
- Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications (2014) (38)
- Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma (2014) (38)
- Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma (2019) (38)
- Contrast‐enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases (2015) (38)
- A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial). (2019) (38)
- Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. (2012) (37)
- In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. (1990) (37)
- Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial (2017) (37)
- Antitumor Activity of BIBF 1120, a Triple Angiokinase Inhibitor, and Use of VEGFR2+pTyr+ Peripheral Blood Leukocytes as a Pharmacodynamic Biomarker In Vivo (2010) (37)
- Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma (2013) (37)
- Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of submucosal tumors of the upper gastrointestinal tract (2017) (37)
- Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2 (2017) (37)
- Endoscopic Ultrasonography and Contrast-Enhanced Endoscopic Ultrasonography (2011) (37)
- Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial (2014) (37)
- Endoscopic Ultrasound-Guided Neurolysis in Pancreatic Cancer (2011) (37)
- Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib (2017) (36)
- Supplementation of pancreatic digestive enzymes alters the composition of intestinal microbiota in mice. (2018) (36)
- Preliminary study of contrast-enhanced harmonic endosonography with second-generation contrast agents (2008) (36)
- Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. (2007) (36)
- Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model. (1991) (36)
- The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development (2017) (36)
- Diagnosis of pancreatic tumors by endoscopic ultrasonography. (2010) (36)
- Factors predicting through-the-scope gastroduodenal stenting outcomes in patients with gastric outlet obstruction: a large multicenter retrospective study in West Japan. (2016) (36)
- Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel (2003) (35)
- Rescue EUS-guided intrahepatic biliary drainage for malignant hilar biliary stricture after failed transpapillary re-intervention (2017) (35)
- Phase I/II study of the pharmacokinetics, safety and efficacy of S‐1 in patients with advanced hepatocellular carcinoma (2010) (35)
- Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib (2019) (35)
- A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy (2020) (35)
- A novel biomarker TERTmRNA is applicable for early detection of hepatoma (2010) (35)
- Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma (2017) (35)
- Clinical-Radiomic Analysis for Pretreatment Prediction of Objective Response to First Transarterial Chemoembolization in Hepatocellular Carcinoma (2021) (34)
- Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma (2014) (34)
- Involvement of Angiotensin II and Reactive Oxygen Species in Pancreatic Fibrosis (2011) (34)
- Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma (2007) (34)
- Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody (2021) (34)
- Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel? (2021) (34)
- Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma (2007) (34)
- Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives (2016) (34)
- Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies (2019) (34)
- Dual‐energy computed tomography for non‐invasive staging of liver fibrosis: Accuracy of iodine density measurements from contrast‐enhanced data (2018) (33)
- Contrast-enhanced harmonic endoscopic ultrasonography for assessment of lymph node metastases in pancreatobiliary carcinoma. (2016) (33)
- Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial (2017) (33)
- Defect Reperfusion Imaging, a Newly Developed Novel Technology using Sonazoid in the Treatment of Hepatocellular Carcinoma (2008) (33)
- Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience (2021) (33)
- Role of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Magnetic Resonance Imaging in the Management of Hepatocellular Carcinoma: Consensus at the Symposium of the 48th Annual Meeting of the Liver Cancer Study Group of Japan (2013) (33)
- Needs for hepatocellular carcinoma control policy in the Asia-Pacific region. (2011) (33)
- KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. (2018) (33)
- Detection of Helicobacter pylori gene by means of immunomagnetic separation-based polymerase chain reaction in feces. (1998) (33)
- Stent migration into the abdominal cavity after EUS-guided hepaticogastrostomy. (2017) (33)
- Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis (2016) (33)
- Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study. (2009) (33)
- LBA-3 CheckMate 459: Long-term (minimum follow-up 33.6 months) survival outcomes with nivolumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma (2020) (32)
- Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma (2016) (32)
- A randomised phase II study of TSU-68 in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. (2013) (32)
- Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy (2019) (32)
- Endoscopic ultrasound: contrast enhancement. (2012) (32)
- Ultrasound Fusion Imaging of Hepatocellular Carcinoma: A Review of Current Evidence (2014) (32)
- Outcomes of Nontransplant Potentially Curative Therapy for Early-Stage Hepatocellular Carcinoma in Child-Pugh Stage A Cirrhosis Is Comparable with Liver Transplantation (2007) (32)
- Transgastric endoscopic ultrasound (EUS)-guided gallbladder drainage for acute cholecystitis. (2009) (31)
- Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan. (2018) (31)
- The chances of hepatic resection curing hepatocellular carcinoma. (2019) (31)
- Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. (2008) (31)
- Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice (2010) (31)
- Utility of Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting for Malignant Biliary Obstruction after Failed Endoscopic Retrograde Cholangiopancreatography (2017) (31)
- A study of ramucirumab (LY3009806) versus placebo in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein (REACH-2). (2018) (31)
- A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma (2011) (31)
- Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases (2010) (31)
- Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade (2020) (30)
- Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial (2021) (30)
- Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma (2010) (30)
- Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of localized gallbladder lesions (2018) (30)
- [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver]. (1991) (30)
- Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of patients with elevated {alpha}-fetoprotein (AFP) from the randomized phase III REACH study. (2015) (30)
- Association between overall survival and adverse events with lenvatinib treatment in patients with hepatocellular carcinoma (REFLECT). (2019) (30)
- Comparison of standard-dose and low-dose gemcitabine regimens in pancreatic adenocarcinoma patients: a prospective randomized trial (2005) (30)
- Sonographic diagnosis of pancreatic islet cell tumor: Value of intermittent harmonic imaging (2001) (30)
- RICK/RIP2 is a NOD2-independent nodal point of gut inflammation. (2019) (30)
- Des-γ-carboxy prothrombin (PIVKA-II) and α-fetoprotein producing IIc-type early gastric cancer (1992) (30)
- Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. (2009) (30)
- Cronkhite-Canada syndrome associated with triple gastric cancers: a case report. (1999) (30)
- Dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study (2014) (29)
- Targeted therapy for liver cancer: updated review in 2012. (2012) (29)
- Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images (2005) (29)
- Hepatic angiomyolipoma pre‐operatively diagnosed by imaging (1993) (29)
- Small hepatocellular carcinomas in chronic liver disease: detection with SPECT. (1986) (28)
- Endoscopic ultrasonography with three miniature probes of different frequency is an accurate diagnostic tool for endoscopic submucosal dissection. (2007) (28)
- Liver damage related to immune checkpoint inhibitors (2019) (28)
- Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting (2018) (28)
- Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial (2018) (28)
- Gd-EOB-DTPA-MRI Could Predict WNT/β-Catenin Mutation and Resistance to Immune Checkpoint Inhibitor Therapy in Hepatocellular Carcinoma (2020) (28)
- Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial. (2021) (28)
- Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab (2021) (28)
- Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040. (2021) (28)
- Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease (2017) (28)
- Nivolumab dose escalation and expansion in patients with advanced hepatocellular carcinoma (HCC): The CheckMate 040 study. (2017) (28)
- Depiction of Portal Supply in Early Hepatocellular Carcinoma and Dysplastic Nodule: Value of Pure Arterial Ultrasound Imaging in Hepatocellular Carcinoma (2010) (27)
- Ultrasound-ultrasound image overlay fusion improves real-time control of radiofrequency ablation margin in the treatment of hepatocellular carcinoma (2018) (27)
- Hepatocellular Carcinoma in Child-Pugh C Cirrhosis: Prognostic Factors and Survival Benefit of Nontransplant Treatments (2013) (27)
- Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma (2020) (27)
- Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients (2018) (27)
- Heterogeneity and Subclassification of Barcelona Clinic Liver Cancer Stage B (2016) (27)
- Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves. (2006) (27)
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
- Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting (2020) (27)
- Therapeutic Response Assessment of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: Ultrasonography, CT and MR Imaging (2013) (27)
- Recent Progress in Radiofrequency Ablation Therapy for Hepatocellular Carcinoma (2014) (27)
- Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011) (2020) (27)
- Correlation between hyporesponsiveness to Toll‐like receptor ligands and liver dysfunction in patients with chronic hepatitis C virus infection (2011) (27)
- Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study (2016) (27)
- Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer (2014) (27)
- Hepatocellular adenoma in type Ia glycogen storage disease (2001) (26)
- Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma (2015) (26)
- Autoimmune Hepatitis and Immunoglobulin G4-Associated Autoimmune Hepatitis (2013) (26)
- Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort (2020) (26)
- Association of Gankyrin and Stemness Factor Expression in Human Colorectal Cancer (2013) (26)
- Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: A nationwide survey of the Liver Cancer Study Group of Japan. (2020) (26)
- Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013) (2021) (26)
- Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009 (2011) (26)
- Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2 (2020) (26)
- In vivo functional imaging using receptor-binding radiopharmaceuticals. Technetium 99m-galactosyl-neoglycoalbumin as a model. (1993) (26)
- Radiofrequency Ablation for Hepatocellular Carcinoma Measuring 2 cm or Smaller: Results and Risk Factors for Local Recurrence (2014) (26)
- Endoscopic characteristics of colorectal serrated lesions. (2011) (26)
- Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 (2020) (25)
- PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy (2008) (25)
- The clinical characteristics, endoscopic treatment, and prognosis for patients presenting with duodenal varices. (2008) (25)
- Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis. (2002) (25)
- Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study (2018) (25)
- Ischemia of rat stomach mobilizes ECL cell histamine. (2005) (25)
- Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience (2012) (25)
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Where Are We Now? (2015) (25)
- Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy (2011) (25)
- Needle-Tract Seeding on the Proximal Gastric Wall After EUS-Guided Fine-Needle Aspiration of a Pancreatic Mass (2016) (25)
- The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma (2021) (25)
- Functional hepatic imaging with receptor-binding radiopharmaceutical: Clinical potential as a measure of functioning hepatocyte mass (1991) (25)
- Autoimmune hepatitis and IgG4-related disease (2019) (25)
- Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective study (2021) (25)
- Endoscopic retrograde extraction of common bile duct stones with drip infusion of isosorbide dinitrate. (1992) (25)
- Validation of Three Staging Systems for Hepatocellular Carcinoma (JIS Score, Biomarker-Combined JIS Score and BCLC System) in 4,649 Cases from a Japanese Nationwide Survey (2014) (25)
- Superiority of CT Arterioportal Angiography to Contrast-Enhanced CT and MRI in the Diagnosis of Hepatocellular Carcinoma in Nodules Smaller than 2 cm (2007) (24)
- Impact of avascular areas, as measured by contrast-enhanced harmonic EUS, on the accuracy of FNA for pancreatic adenocarcinoma. (2018) (24)
- Genome-Wide Profiling of DNA Methylation and Tumor Progression in Human Hepatocellular Carcinoma (2014) (24)
- [Tumor hemodynamics in hepatic nodules associated with liver cirrhosis: relationship between cancer progression and tumor hemodynamic change]. (1991) (24)
- Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion (2019) (24)
- Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil (2015) (24)
- 619OJET-HCC: A phase 3 randomized, double-blind, placebo-controlled study of tivantinib as a second-line therapy in patients with c-Met high hepatocellular carcinoma (2017) (24)
- CheckMate 459: Health-related quality of life (HRQoL) in a randomized, multicenter phase III study of nivolumab (NIVO) versus sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC). (2020) (24)
- Treatment response assessment of radiofrequency ablation for hepatocellular carcinoma: usefulness of virtual CT sonography with magnetic navigation. (2012) (24)
- Recent Updates on the Relationship between Cancer and Autoimmune Pancreatitis (2019) (24)
- New endoscopic ultrasonography techniques for pancreaticobiliary diseases (2016) (24)
- Percutaneous Radiofrequency Ablation of Sonographically Unidentifiable Liver Tumors (2007) (24)
- The gross classification of hepatocellular carcinoma: Usefulness of contrast‐enhanced US (2014) (24)
- Clinical efficacy and safety of endoscopic ultrasound‐guided gallbladder drainage replacement of percutaneous drainage: A multicenter retrospective study (2018) (24)
- Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease (2020) (24)
- Final analysis of serum biomarkers in patients (pts) from the phase III study of lenvatinib (LEN) vs sorafenib (SOR) in unresectable hepatocellular carcinoma (uHCC) [REFLECT]. (2018) (24)
- US-US Fusion Imaging in Radiofrequency Ablation for Liver Metastases (2016) (23)
- Hand-Foot Syndrome and Post-Progression Treatment Are the Good Predictors of Better Survival in Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Study (2017) (23)
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Subgroup analyses from CheckMate 040. (2020) (23)
- Patient-reported outcomes (PROs) from the Phase III IMbrave150 trial of atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-line treatment (tx) for patients (pts) with unresectable hepatocellular carcinoma (HCC). (2020) (23)
- Atypical Large Well-Differentiated Hepatocellular Carcinoma with Benign Nature: A New Clinical Entity (2004) (23)
- Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial (2021) (23)
- New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode (2019) (23)
- A Novel Treatment Strategy for Patients with Intermediate-Stage HCC Who Are Not Suitable for TACE: Upfront Systemic Therapy Followed by Curative Conversion (2021) (23)
- LBA16RAMUCIRUMAB (RAM) AS SECOND-LINE TREATMENT IN PATIENTS (PTS) WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) FOLLOWING FIRST-LINE THERAPY WITH SORAFENIB: RESULTS FROM THE RANDOMIZED PHASE III REACH STUDY (2014) (23)
- EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis (2020) (23)
- Hepatic peribiliary cysts: clinically harmless disease with potential risk due to gradual increase in size and number (2001) (23)
- Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B (2019) (23)
- Characterization of Pancreatic Tumors with Quantitative Perfusion Analysis in Contrast-Enhanced Harmonic Endoscopic Ultrasonography (2017) (22)
- Risk Factors for Postoperative Bleeding in Endoscopic Submucosal Dissection of Colorectal Tumors (2017) (22)
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to Bedside (2011) (22)
- Plasma concentrations of angiogenesis-related molecules in patients with pancreatic cancer. (2012) (22)
- The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization (2017) (22)
- Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study (2021) (22)
- Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis (2019) (22)
- Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy (2018) (22)
- Inhibition of hepatocellular carcinoma by PegIFNα-2a in patients with chronic hepatitis C: a nationwide multicenter cooperative study (2012) (22)
- Alpha-fetoprotein-L3: Useful or Useless for Hepatocellular Carcinoma? (2013) (22)
- Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study (2016) (22)
- Pembrolizumab for the Treatment of Hepatocellular Carcinoma (2019) (22)
- Detection of tumor parenchymal blood flow in hepatic tumors: value of second harmonic imaging with a galactose-based contrast agent. (2001) (22)
- A multicenter, open-label, phase 3 trial to compare the efficacy and safety of lenvatinib (E7080) versus sorafenib in first-line treatment of subjects with unresectable hepatocellular carcinoma. (2014) (21)
- Influence of Liver Inflammation on Liver Stiffness Measurement in Patients with Autoimmune Hepatitis Evaluation by Combinational Elastography (2017) (21)
- Acute spinal cord infarction after EUS-guided celiac plexus neurolysis. (2016) (21)
- Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection (2019) (21)
- 256 JIS scoring system combined with 3 tumor makers (modified JIS score) is an exellent prognostic staging system for hepatocellular carcinoma (HCC): Analysis of 4525 patients with HCC (2004) (21)
- Association between a focal spared area in the fatty liver and intrahepatic efferent blood flow from the gallbladder wall: evaluation with color Doppler sonography. (1999) (21)
- Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases (2017) (21)
- Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in Japan (2019) (21)
- Hepatic angiomyolipoma: identification of an efferent vessel to be hepatic vein by contrast-enhanced harmonic ultrasound. (2005) (21)
- Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori (2017) (21)
- What Is the Best Time to Evaluate Treatment Response after Radiofrequency Ablation of Hepatocellular Carcinoma Using Contrast-Enhanced Sonography? (2007) (21)
- Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma (2021) (21)
- Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B (2013) (21)
- TACTICS: Final overall survival (OS) data from a randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients (pts) with hepatocellular carcinoma (HCC). (2021) (21)
- A Newly Developed Shear Wave Elastography Modality: With a Unique Reliability Index (2015) (21)
- Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey (2017) (21)
- Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial) (2021) (21)
- Inflammatory pseudotumor of the liver in a patient with chronic hepatitis C: Difficulty in differentiating it from hepatocellular carcinoma (1999) (21)
- Pathological Diagnosis of Benign Hepatocellular Nodular Lesions Based on the New World Health Organization Classification (2014) (21)
- Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience (2015) (21)
- Evaluation of anti-migration properties of biliary covered self-expandable metal stents. (2016) (21)
- Biomarkers and Personalized Sorafenib Therapy (2014) (20)
- Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma (2011) (20)
- Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC bridge study: First characterization of the full study population. (2012) (20)
- Impact of Interferon Therapy after Curative Treatment of Hepatocellular Carcinoma (2008) (20)
- Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. (2013) (20)
- Heat Shock Protein A4 Controls Cell Migration and Gastric Ulcer Healing (2015) (20)
- Response Evaluation Criteria in Cancer of the Liver version 5 (RECICL 2019 revised version) (2019) (20)
- Hypothermia Protects against Fulminant Hepatitis in Mice by Reducing Reactive Oxygen Species Production (2013) (20)
- Endoscopic ultrasound‐guided choledochoduodenostomy using a thin stent delivery system in patients with unresectable malignant distal biliary obstruction: A prospective multicenter study (2019) (20)
- Identifying and prioritizing strategies for comprehensive liver cancer control in Asia (2011) (20)
- Prediction of Hepatocellular Carcinoma Incidence Risk by Ultrasound Elastography (2014) (20)
- Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1 (2020) (20)
- Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma (2021) (20)
- mTOR Inhibitor for the Treatment of Hepatocellular Carcinoma (2011) (20)
- P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1 (2020) (20)
- Small invasive ductal carcinoma of the pancreas distinct from branch duct intraductal papillary mucinous neoplasm. (2009) (20)
- Urgent endoscopic ultrasound-guided choledochoduodenostomy for acute obstructive suppurative cholangitis-induced sepsis. (2016) (20)
- Clinical Characteristics of Non-B Non-C Hepatocellular Carcinoma: A Single-Center Retrospective Study (2011) (20)
- Randomized phase II trial of intravenous RO5137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168). (2014) (20)
- Percutaneous endoscopic gastrostomy with Funada-style gastropexy greatly reduces the risk of peristomal infection (2015) (20)
- Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study (2017) (20)
- P38alpha Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen Species (2011) (20)
- Clinical Factors Predicting the Effect of Tolvaptan for Refractory Ascites in Patients with Decompensated Liver Cirrhosis (2016) (20)
- Characteristics of Hypovascular versus Hypervascular Well-Differentiated Hepatocellular Carcinoma Smaller Than 2 cm - Focus on Tumor Size, Markers and Imaging Detectability (2015) (19)
- Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma (2015) (19)
- Des-gamma-carboxy prothrombin (PIVKA-II) and alpha-fetoprotein-producing IIc-type early gastric cancer. (1992) (19)
- A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma (2020) (19)
- Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells. (2019) (19)
- Comparison of Two-Dimensional Shear Wave Elastography and Real-Time Tissue Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B (2016) (19)
- Characteristics of Long-Term Survivors following Sorafenib Treatment for Advanced Hepatocellular Carcinoma: Report of a Workshop at the 50th Annual Meeting of the Liver Cancer Study Group of Japan (2014) (19)
- Intranodular Blood Supply Correlates Well with Biological Malignancy Grade Determined by Tumor Growth Rate in Pathologically Proven Hepatocellular Carcinoma (2008) (19)
- Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma (2016) (19)
- Combination therapy with PEG-IFN-α and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53 (2007) (19)
- Ultrasound Elastography Correlates Treatment Response by Antiviral Therapy in Patients with Chronic Hepatitis C (2014) (19)
- Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis (2021) (19)
- Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience (2017) (18)
- Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease (2016) (18)
- Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety across two global randomized Phase 3 studies (REACH-2 and REACH). (2018) (18)
- Abstract CT061: A Phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results (2019) (18)
- The oncoprotein gankyrin promotes the development of colitis-associated cancer through activation of STAT3 (2017) (18)
- Characteristic Pattern of Reactivation of Hepatitis B Virus during Chemotherapy for Solid Cancers (2012) (18)
- Differentiation of Hepatic Tumors by Color Doppler Imaging: Role of the Maximum Velocity and the Pulsatility Index of the Intratumoral Blood Flow Signal (2004) (18)
- Hepatocellular carcinoma development in diabetic patients: a nationwide survey in Japan (2021) (18)
- A Paradigm Change in the Treatment Strategy for Hepatocellular Carcinoma (2020) (18)
- Malignant Transformation of Hepatocellular Adenoma (2016) (18)
- Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced MR (2011) (18)
- Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial (2019) (18)
- Impact of Tight Junction Protein ZO-1 and TWIST Expression on Postoperative Survival of Patients with Hepatocellular Carcinoma (2016) (18)
- Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer (2016) (18)
- Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis (2018) (18)
- Current treatment status of polycystic liver disease in Japan (2014) (18)
- Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos) (2019) (18)
- Afferent and Efferent Vessels of Premalignant and Overt Hepatocellular Carcinoma: Observation by Color Doppler Imaging (2004) (18)
- Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma (2020) (18)
- Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma (2016) (18)
- Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial (2020) (18)
- Health‐related quality‐of‐life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE‐240 (2020) (18)
- Intrahepatic portosystemic venous shunt in liver cirrhosis: is it congenital or acquired? (1993) (18)
- Randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. (2018) (18)
- Hepatocellular Carcinoma with Obstructive Jaundice: Endoscopic and Percutaneous Biliary Drainage (2012) (18)
- Clinical Significance of Epigenetic Alterations in Human Hepatocellular Carcinoma and Its Association with Genetic Mutations (2016) (17)
- Involvement of Heat Shock Protein A4/Apg-2 in Refractory Inflammatory Bowel Disease (2014) (17)
- M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in Asian patients with pretreated biliary tract cancer: Preliminary results from a phase I trial. (2018) (17)
- Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib (2021) (17)
- Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis (2016) (17)
- VALUE OF COMPUTED TOMOGRAPHY FOR EVALUATING THE INJECTION SITE IN ENDOSONOGRAPHY‐GUIDED CELIAC PLEXUS NEUROLYSIS (2006) (17)
- Combination Therapy with S-1 and Pegylated Interferon Alpha for Advanced Hepatocellular Carcinoma (2008) (17)
- Transient portal vein thrombosis caused by radiofrequency ablation for hepatocellular carcinoma (2003) (17)
- Mechanical Model Analysis for Quantitative Evaluation of Liver Fibrosis Based on Ultrasound Tissue Elasticity Imaging (2012) (17)
- Breakthrough Imaging in Hepatocellular Carcinoma (2015) (17)
- Phase I/II study of E7080 (lenvatinib), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Initial assessment of response rate. (2012) (17)
- Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma (2018) (17)
- Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib (2014) (17)
- Various Contrast-Enhanced Imaging Modes After Administration of Levovist (2003) (17)
- Demonstration of quality of care measurement using the Japanese liver cancer registry (2011) (17)
- Artificial Intelligence in Medical Imaging and Its Application in Sonography for the Management of Liver Tumor (2020) (16)
- Accuracy of Real-Time Tissue Elastography for the Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis B: A Prospective Multicenter Study (2014) (16)
- Partial Pancreatic Parenchymal Atrophy Is a New Specific Finding to Diagnose Small Pancreatic Cancer (≤10 mm) Including Carcinoma in Situ: Comparison with Localized Benign Main Pancreatic Duct Stenosis Patients (2020) (16)
- Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma (2015) (16)
- Through-the-mesh technique after endoscopic ultrasonography-guided hepaticogastrostomy: a novel re-intervention method (2016) (16)
- Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC). (2020) (16)
- Effects of decorin on the expression of α-smooth muscle actin in a human myofibroblast cell line (2007) (16)
- Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma. (2020) (16)
- Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy (2021) (16)
- Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology (2019) (16)
- Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide (2009) (16)
- Diagnosis of Hepatocellular Carcinoma with Non-Invasive Imaging: a Plea for Worldwide Adoption of Standard and Precise Terminology for Describing Enhancement Criteria (2017) (16)
- Hepatocellular carcinoma associated with secondary haemochromatosis in non-cirrhotic liver: a case report. (2003) (16)
- LBA30Analysis of serum biomarkers (BM) in patients (pts) from a phase 3 study of lenvatinib (LEN) vs sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC) (2017) (16)
- Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma (2020) (16)
- Magnetic resonance elastography in the assessment of hepatic fibrosis: a study comparing transient elastography and histological data in the same patients (2017) (16)
- LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma (2022) (16)
- Cost-effectiveness of EOB-MRI for Hepatocellular Carcinoma in Japan. (2017) (16)
- Ability of Cytokeratin-18 Fragments and FIB-4 Index to Diagnose Overall and Mild Fibrosis Nonalcoholic Steatohepatitis in Japanese Nonalcoholic Fatty Liver Disease Patients (2017) (16)
- Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma (2016) (16)
- Utility of contrast‐enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms (2020) (16)
- Early Detection and Characterization of Hepatocellular Carcinoma: Value of Imaging Multistep Human Hepatocarcinogenesis (2005) (15)
- Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients (2015) (15)
- Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (15)
- Antiviral therapy for chronic hepatitis B: Combination of nucleoside analogs and interferon. (2015) (15)
- Noninvasive Diagnosis of Liver Fibrosis: Utility of Data Mining of Both Ultrasound Elastography and Serological Findings to Construct a Decision Tree (2014) (15)
- Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis (2022) (15)
- Massive rectal bleeding due to ileal tuberculosis (1999) (15)
- A Case of Pancreatic Carcinoma in situ Diagnosed by Repeated Pancreatic Juice Cytology (2017) (15)
- Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: a phase 2 multicenter study (2021) (15)
- Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma (2021) (15)
- Acute Pancreatitis Associated with Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C, Genotype 1b with High Viral Load (2009) (15)
- Sustained Antiviral Effects and Clearance of Hepatitis Surface Antigen after Combination Therapy with Entecavir and Pegylated Interferon in Chronic Hepatitis B (2018) (14)
- Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency (2018) (14)
- Treatment of hepatocellular carcinoma during the COVID‐19 outbreak: The Working Group report of JAMTT‐HCC (2020) (14)
- Clinical significance of Akt2 in advanced pancreatic cancer treated with erlotinib. (2017) (14)
- Management of Hepatocellular Carcinoma in Japan: Current Trends (2019) (14)
- Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma. (2009) (14)
- Detection of Intratumoral Vascularity in Small Hepatocellular Carcinoma by Coded Phase Inversion Harmonics (2004) (14)
- A multicenter randomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): Analysis of overall survival. (2021) (14)
- The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma (2011) (14)
- Campylobacter fetus meningitis in a patient with Crohn's disease. (2009) (14)
- Color Doppler flow imaging of hepatic focal nodular hyperplasia (1992) (14)
- RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases (2021) (14)
- Treatment Strategies of Intermediate-Stage Hepatocellular Carcinomas in Japan (Barcelona Clinic Liver Cancer Stage B) (2014) (14)
- Multiple hemangiopericytomas of the spleen. (1992) (14)
- Identification of Epigenetically Inactivated Genes in Human Hepatocellular Carcinoma by Integrative Analyses of Methylation Profiling and Pharmacological Unmasking (2014) (14)
- Intrahepatic spontaneous retrograde portal flow in patients with cirrhosis of the liver: reversal by food intake. (2001) (14)
- Evaluation of the Response to Chemotherapy in Advanced Gastric Cancer by Contrast-Enhanced Harmonic EUS. (2011) (14)
- Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma (2022) (14)
- Review of 4th Single Topic Conference on HCC (2007) (14)
- Quantification of Tumor DNA in Serum and Vascular Invasion of Human Hepatocellular Carcinoma (2013) (14)
- A randomized phase II study of TSU-68 in patients (pts) with hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE). (2010) (14)
- Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice (2022) (14)
- Subsequent anticancer medication following first-line lenvatinib: A posthoc responder analysis from the phase 3 REFLECT study in unresectable hepatocellular carcinoma. (2019) (13)
- Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression (2021) (13)
- Eosionophilic pseudotumor of the liver due to Ascaris suum infection. (2002) (13)
- Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review (2018) (13)
- Improved liver metastasis detection using Kupffer-phase imaging in contrast-enhanced harmonic EUS in patients with pancreatic cancer (with video). (2020) (13)
- Baseline liver function and outcomes in the phase III REFLECT study in patients with unresectable hepatocellular carcinoma (uHCC). (2020) (13)
- Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials (2020) (13)
- Two Cases of Histopathologically Advanced (STAGE IV) Early Gastric Cancers (2001) (13)
- Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2020) (13)
- A phase 3, randomized, open-label, multicenter study to compare the efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma. (2018) (13)
- Recent Advances in the Management of Chronic Hepatitis B (2011) (13)
- Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma (2020) (13)
- Impact of COVID-19 on Hepatocellular Carcinoma Management: A Multicountry and Region Study (2021) (13)
- ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses. (2020) (13)
- Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. (2008) (13)
- Diagnostic value of endoscopic ultrasound-guided directional eFLOW in solid pancreatic lesions (2013) (13)
- Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy (2010) (13)
- Hepatocellular Carcinoma with Nodule-in-Nodule Appearance: Demonstration by Contrast-Enhanced Coded Phase Inversion Harmonic Imaging (2004) (13)
- Contrast harmonic ultrasound is a breakthrough technology in the diagnosis and treatment of hepatocellular carcinoma (2001) (13)
- Primary leiomyosarcoma of the colon (2015) (13)
- KEYNOTE-224: Phase II study of pembrolizumab in patients with previously treated advanced hepatocellular carcinoma. (2017) (13)
- Survival by pattern of tumor progression during prior sorafenib (SOR) treatment in patients with hepatocellular carcinoma (HCC) in the phase III RESORCE trial comparing second-line treatment with regorafenib (REG) or placebo (2017) (13)
- IgG4-Related Disease and Innate Immunity. (2016) (13)
- Clinical Analysis of Esophageal Stricture in Patients Treated with Intralesional Triamcinolone Injection after Endoscopic Submucosal Dissection for Superficial Esophageal Cancer (2017) (13)
- TTV Positivity and Transfusion History in Non-B, Non-C Hepatocellular Carcinoma Compared with HBV- and HCV-Positive Cases (2000) (13)
- Clinical Significance of the Genotype and Core Promoter/Pre-Core Mutations in Hepatitis B Virus Carriers (2006) (12)
- Dual-Energy Computed Tomography of the Liver: Uses in Clinical Practices and Applications (2021) (12)
- JSH Consensus Kobe 2009; Diagnosis and Treatment of NASH (2009) (12)
- Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents (2015) (12)
- Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies (2020) (12)
- O-8 Atezolizumab + bevacizumab vs sorafenib for unresectable hepatocellular carcinoma: Results from older adults enrolled in IMbrave150 (2020) (12)
- Heat Shock Protein 27 Expression is Inversely Correlated with Atrophic Gastritis and Intraepithelial Neoplasia (2013) (12)
- The Asian Federation of Societies for Ultrasound in Medicine and Biology (AFSUMB) Guidelines for Contrast-Enhanced Endoscopic Ultrasound. (2021) (12)
- Contrast Harmonic Imaging in the Diagnosis and Treatment of Hepatic Tumors (2003) (12)
- Mucin phenotypic expression and background mucosa of esophagogastric junctional adenocarcinoma (2004) (12)
- A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies (2019) (12)
- PRESENT STATUS AND FUTURE PERSPECTIVE OF EUS‐GUIDED DRAINAGE (2009) (12)
- Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. (2022) (12)
- Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer (2017) (12)
- Dysbiosis-Associated Polyposis of the Colon—Cap Polyposis (2018) (12)
- Elevated Serum ALT Levels during Pegylated Interferon Monotherapy May Be Caused by Hepatic Iron Overload (2008) (12)
- Deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): An exploratory analysis of OPTIMIS—An international observational study assessing the use of sorafenib after TACE. (2018) (12)
- Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Patient reported outcome results across two phase III studies (REACH-2 and REACH). (2018) (12)
- Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC. (2018) (12)
- Association of genetic polymorphisms with interferon‐induced haematologic adverse effects in chronic hepatitis C patients (2009) (12)
- Alpha-fetoprotein (AFP) response in patients with unresectable hepatocellular carcinoma (HCC) in the phase III RESORCE trial (2019) (12)
- Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography. (2003) (12)
- Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma (2010) (12)
- Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis (2020) (12)
- Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma (2021) (12)
- Treatment of Hepatocellular Carcinoma with Child-Pugh C Cirrhosis (2014) (12)
- Paradoxical ulcerative colitis during treatment with secukinumab for psoriasis (2019) (12)
- Chronic Pancreatitis Finding by Endoscopic Ultrasonography in the Pancreatic Parenchyma of Intraductal Papillary Mucinous Neoplasms Is Associated with Invasive Intraductal Papillary Mucinous Carcinoma (2017) (12)
- Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment (2022) (11)
- Ultrasound fusion imaging technologies for guidance in ablation therapy for liver cancer (2020) (11)
- CEA producing primary hepatic carcinoid. (2002) (11)
- Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report. (2002) (11)
- Cytokines produced by innate immune cells in IgG4-related disease (2018) (11)
- Development of multicentric hepatocellular carcinoma after completion of interferon therapy (2002) (11)
- Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis (2021) (11)
- Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma (2022) (11)
- Impact of Multi-Drug Sequential Therapy on Survival in Patients with Unresectable Hepatocellular Carcinoma (2021) (11)
- Radiofrequency Ablation for Hepatic Malignancies: Is Needle Tract Cauterization Necessary for Preventing Iatrogenic Bleeding? (2013) (11)
- FNA Guided By Contrast-Enhanced Harmonic EUS in Pancreatic Tumors (2009) (11)
- Endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction with surgically altered anatomy: a multicenter prospective registration study (2020) (11)
- Pembrolizumab (Pembro) therapy vs best supportive care (BSC) in advanced hepatocellular carcinoma (HCC): KEYNOTE-240. (2019) (11)
- Computer aided diagnosis system developed for ultrasound diagnosis of liver lesions using deep learning (2019) (11)
- Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study (2019) (11)
- Response Evaluation Criteria in Cancer of the Liver (RECICL 2021 revised version) (2010) (11)
- Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection (2017) (11)
- Autoimmune Pancreatitis Mouse Model (2018) (11)
- A novel biliary cannulation method for difficult cannulation cases using a unique, uneven, double-lumen cannula (Uneven method) (2018) (11)
- Objective Response by mRECIST Is an Independent Prognostic Factor of Overall Survival in Systemic Therapy for Hepatocellular Carcinoma (2019) (11)
- Effective use of the Japan Narrow Band Imaging Expert Team classification based on diagnostic performance and confidence level (2019) (11)
- Synthesis and radiolabeling of galactosyl human serum albumin. (1994) (11)
- The Prognostic Value of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma for Predicting Metastasis after Curative Resection (2013) (11)
- Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab (2020) (11)
- Adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. (2021) (11)
- Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function? (2012) (11)
- Tumor markers after radiofrequency ablation therapy for hepatocellular carcinoma. (2008) (11)
- Histopathological Diagnosis of Early HCC through Biopsy: Efficacy of Victoria Blue and Cytokeratin 7 Staining (2012) (11)
- Hemodynamic characteristics of early stage hepatocellular carcinoma: In vivo evaluation with vascular imagings. (1992) (11)
- Risk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response (2016) (11)
- Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update (2021) (10)
- Decreased Blood Flow after Sorafenib Administration Is an Imaging Biomarker to Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma (2014) (10)
- Role of Immune Checkpoint Blockade in the Treatment for Human Hepatocellular Carcinoma (2017) (10)
- Accumulation of Tc-99m Methylene Diphosphonate in Calcified Metastatic Lesions of the Liver from Colonic Carcinoma: Comparison with Calcification on X-ray Computed Tomogram (1985) (10)
- PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate (2010) (10)
- Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma (2018) (10)
- Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm (2017) (10)
- Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system (2017) (10)
- Multistep hepatocarcinogenesis from a dysplastic nodule to well-differentiated hepatocellular carcinoma in a patient with alcohol-related liver cirrhosis. (2007) (10)
- Hemodynamic and morphologic changes of peripheral hepatic vasculature in cirrhotic liver disease: a preliminary study using contrast-enhanced coded phase inversion harmonic ultrasonography. (2005) (10)
- Response evaluation criteria in cancer of the liver (RECICL 2015 revised version) (2015) (10)
- Adjuvant Immunotherapy after Curative Treatment for Hepatocellular Carcinoma (2021) (10)
- Serum amyloid A and C‐reactive protein positive nodule in alcoholic liver cirrhosis, hard to make definite diagnosis (2014) (10)
- Stent migration during EUS-guided hepaticogastrostomy in a patient with massive ascites: Troubleshooting using additional EUS-guided antegrade stenting. (2017) (10)
- Image Guidance in Ablation for Hepatocellular Carcinoma: Contrast-Enhanced Ultrasound and Fusion Imaging (2021) (10)
- Efficacy, safety, and health-related quality of life (HRQoL) of regorafenib in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: Results of the international, double-blind phase 3 RESORCE trial (2016) (10)
- Clinical Features of Vascular Disorders Associated with Chronic Hepatitis Virus Infection (2014) (10)
- Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity. (1991) (10)
- Utility of a 20G needle with a core trap in EUS-guided fine-needle biopsy for gastric submucosal tumors: A multicentric prospective trial (2021) (10)
- A randomized, double-blind, placebo-controlled phase III study of S-1 in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE). (2015) (10)
- A multicenter nonrandomized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF cohort trial). (2019) (10)
- Effects of decorin on the expression of alpha-smooth muscle actin in a human myofibroblast cell line. (2008) (10)
- Treatment of large and/or multiple hepatic malignancies: open surgical approaches of radiofrequency ablation. (2007) (10)
- Pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC): KEYNOTE-224 update. (2018) (10)
- Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040 (2017) (10)
- Future Treatment Option for Hepatocellular Carcinoma: A Focus on Brivanib (2011) (10)
- Comparison of modified (m)RECISTand RECIST 1.1 assessments in the phase 3 RESORCE trial comparing regorafenib and placebo in patients with hepatocellular carcinoma who progressed during sorafenib treatment (2017) (10)
- Usefulness of the Extracted-Overlay Function in CT/MR-Ultrasonography Fusion Imaging for Radiofrequency Ablation of Hepatocellular Carcinoma (2013) (10)
- Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial (2022) (10)
- Malignant Transformation of Hepatocellular Adenoma: How Frequently Does It Happen? (2014) (10)
- Endoscopic ultrasound (EUS)-guided transluminal endoscopic removal of gallstones. (2010) (9)
- Radiofrequency ablation combined with reduction of hepatic blood flow: effect of Lipiodol on coagulation diameter and ablation time in normal pig liver. (2007) (9)
- Cecal intussusception in an adult with Cronkhite-Canada syndrome relieved by colonoscopy. (2010) (9)
- Hypervascular liver nodules in heavy drinkers of alcohol. (2004) (9)
- Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders (2017) (9)
- Impaired expression of ATP‐binding cassette transporter G2 and liver damage in erythropoietic protoporphyria (2015) (9)
- Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm (2017) (9)
- Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma (2022) (9)
- Comparison of argon plasma coagulation and paravariceal injection sclerotherapy with 1% polidocanol in mucosa-fibrosing therapy for esophageal varices (2004) (9)
- Value of additional endoscopic ultrasonography for surveillance after surgical removal of intraductal papillary mucinous neoplasms (2018) (9)
- Why Does Every Hepatocellular Carcinoma Clinical Trial Using Molecular Targeted Agents Fail? (2012) (9)
- Novel method of biliary cannulation for patients with Roux‐en‐Y anastomosis using a unique, uneven, double‐lumen cannula (Uneven method) (2018) (9)
- 6500 ORAL Second Interim Results of the GIDEON (Global Investigation of Therapeutic DEcisions in HCC and of Its Treatment With SorafeNib) Study – Barcelona-Clinic Liver Cancer (BCLC) Stage Subgroup Analysis (2011) (9)
- Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP) following first-line sorafenib: Pooled efficacy and safety in Japanese patients across two global randomized phase III studies (REACH-2 and REACH). (2019) (9)
- Activation of c‐Jun N‐terminal kinase in non‐cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma (2012) (9)
- Focal fatty infiltration of the liver in acute alcoholic liver injury: hot spots with radiocolloid SPECT scan. (1989) (9)
- Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma: Reply (2009) (9)
- Prediction of Embolization Area after Conventional Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using SYNAPSE VINCENT (2016) (9)
- Novel concept of bared type metallic stent for endoscopic bilateral stent‐in‐stent placement in patients with hilar malignant biliary obstruction (with video) (2019) (9)
- Nivolumab in sorafenib-naive and - experienced patients with advanced hepatocellular carcinoma (HCC): checkMate 040 study (2017) (9)
- Evidence and Consensus on the Management of Hepatocellular Carcinoma: Update 2015 (2015) (9)
- In situ carcinoma of pancreas diagnosed by EUS-FNA. (2008) (9)
- Multiple hypervascular liver nodules in a heavy drinker of alcohol (2005) (9)
- Review of current staging systems for hepatocellular carcinoma (2007) (9)
- Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation (2009) (9)
- Hepatic DNA Methylation Is Affected by Hepatocellular Carcinoma Risk in Patients with and without Hepatitis Virus (2015) (9)
- Nationwide survey in Japan regarding splenectomy/partial splenic embolization for interferon treatment targeting hepatitis C virus‐related chronic liver disease in patients with low platelet count (2014) (9)
- Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials (2018) (9)
- Comparison between T1 relaxation time of Gd‐EOB‐DTPA‐enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver (2015) (9)
- PANCREATIC DUCTAL DRAINAGE BY ENDOSCOPIC ULTRASOUND‐ASSISTED RENDEZVOUS TECHNIQUE FOR PAIN CAUSED BY DUCTAL STRICTURE WITH CHRONIC PANCREATITIS (2010) (9)
- Hepatocellular carcinoma transforming from dysplastic nodule with background of non-B non-C chronic persistent hepatitis. (2000) (9)
- Histological diagnosis and grading of pancreatic neuroendocrine tumor by endoscopic ultrasound-guided fine needle biopsy using a 25-gauge needle with a core trap: A multicenter prospective trial. (2020) (9)
- What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure? (2021) (9)
- Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment. (2017) (9)
- Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study (2018) (9)
- Endoscopic ultrasound-guided biliary drainage using a newly designed metal stent with a thin delivery system: a preclinical study in phantom and porcine models (2018) (9)
- Durvalumab Plus Tremelimumab: A Novel Combination Immunotherapy for Unresectable Hepatocellular Carcinoma (2022) (9)
- Hepatocellular carcinoma mimicking cavernous hemangioma on angiography and contrast enhanced harmonic ultrasonography. A case report. (2003) (9)
- The Feasibility of 18-mm-Diameter Colonic Stents for Obstructive Colorectal Cancers (2017) (8)
- Usefulness of a New Immunoradiometric Assay of HCV Core Antigen to Predict Virological Response during PEG-IFN/RBV Combination Therapy for Chronic Hepatitis with High Viral Load of Serum HCV RNA Genotype 1b (2008) (8)
- Scirrhous hepatocellular carcinoma displaying atypical findings on imaging studies. (2009) (8)
- Current Status of Hepatocellular Carcinoma Treatment in Japan (2012) (8)
- Molecular mechanisms of portal vein tolerance (2008) (8)
- Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience Second Analysis (2015) (8)
- Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis. (2022) (8)
- Clinical Significance of Bmi1 Expression in Inflammatory Bowel Disease (2017) (8)
- 618OHealth-related quality of Life (HRQOL) and disease symptoms in patients with unresectable hepatocellular carcinoma (HCC) treated with lenvatinib (LEN) or sorafenib (SOR) (2017) (8)
- Reintervention for stent occlusion after endoscopic ultrasound-guided hepaticogastrostomy with novel use of a precut needle-knife (2018) (8)
- Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis (2020) (8)
- Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline α-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study. (2019) (8)
- Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts (2022) (8)
- Ramucirumab for patients with intermediate-stage hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): pooled results from two phase 3 studies (REACH and REACH-2) (2020) (8)
- Efficacy of a modified double-guidewire technique using an uneven double lumen cannula (uneven method) in patients with surgically altered gastrointestinal anatomy (with video) (2019) (8)
- AB053. P-21. M7824 (MSB0011359C), a bifunctional fusion protein targeting transforming growth factor β (TGF-β) and PD-L1, in Asian patients with pretreated biliary tract cancer (BTC): efficacy by BTC subtype (2019) (8)
- Contrast-enhanced ultrasonography with Sonazoid in hepatocellular carcinoma diagnosis (2020) (8)
- Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma (2015) (8)
- Gender Differences in the Livers of Patients with Hepatocellular Carcinoma and Chronic Hepatitis C Infection (2012) (8)
- Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study (2017) (8)
- Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease (2021) (8)
- Combination immunotherapy with anti-VEGF/TKI for hepatocellular carcinoma: present and future perspective. (2021) (8)
- Hepatic portal venous gas associated with Klebsiella oxytoca infection in the absence of preceding antibiotic treatment (2019) (8)
- Phase II study of front-line dovitinib (TKI258) versus sorafenib in patients (Pts) with advanced hepatocellular carcinoma (HCC). (2015) (8)
- Outcome and Early Viral Dynamics with Viral Mutation in PEG-IFN/RBV Therapy for Chronic Hepatitis in Patients with High Viral Loads of Serum HCV RNA Genotype 1b (2010) (8)
- Novel metallic stent designed for endoscopic bilateral stent-in-stent placement in patients with hilar malignant biliary obstruction (2018) (8)
- Contrast advanced dynamic flow imaging and contrast pulse subtraction imaging: Preliminary results in hepatic tumors (2002) (8)
- Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC). (2016) (8)
- Case Report: New-Onset Rheumatoid Arthritis Following COVID-19 Vaccination (2022) (8)
- Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study (2022) (8)
- Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury (2017) (8)
- Long-Term Follow-Up of Atypical Progressive Focal Nodular Hyperplasia Increasing in Size and Number Implicates Its Pathogenesis (2008) (8)
- Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma (2017) (8)
- Tissue harmonic versus contrast‐enhanced harmonic endoscopic ultrasonography for the diagnosis of pancreatic tumors: Prospective multicenter study (2021) (8)
- A proposal of the modified liver damage classification for hepatocellular carcinoma. (2006) (8)
- Objective Response Predicts Survival in Advanced Hepatocellular Carcinoma treated with Systemic Therapies. (2021) (8)
- Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study (2017) (8)
- Hyperenhanced Rim Surrounding Liver Metastatic Tumors in the Postvascular Phase of Sonazoid-Enhanced Ultrasonography: A Histological Indication of the Presence of Kupffer Cells (2015) (8)
- First interim results of the global investigation of therapeutic decisions in hepatocellular carcinoma (HCC) and of its treatment with sorafenib (GIDEON) study: Use of sorafenib (Sor) by oncologists and nononcologists in the management of HCC. (2011) (8)
- Hepatic nodular lesions caused by abnormal hepatic circulation: etiological and clinical aspects (2003) (8)
- Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma (2022) (7)
- Intracystic hemorrhage in a patient of polycystic kidney with renocolic fistula diagnosed by contrast-enhanced ultrasonography. (2008) (7)
- Prophylactic Suturing Closure Is Recommended after Endoscopic Treatment of Colorectal Tumors in Patients with Antiplatelet/Anticoagulant Therapy (2017) (7)
- Ramucirumab (RAM) for sorafenib intolerant patients with hepatocellular carcinoma (HCC) and elevated baseline alpha fetoprotein (AFP): Outcomes from two randomized phase 3 studies (REACH, REACH2). (2019) (7)
- Anisakis in a biopsy specimen from the edge of a gastric ulcer: report of a case. (2004) (7)
- Growth speed of hepatocellular carcinoma. Relationship with arterial vascularity evaluated by US angiography. (1992) (7)
- Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon (2015) (7)
- [Estimation of hepatic functional reserve by asialoglycoprotein receptor-binding, radiolabeled synthetic ligand Tc-99m-galactosyl-neoglycoalbumin--preclinical and clinical studies]. (1987) (7)
- Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging (2003) (7)
- The efferent blood flow of early hepatocellular carcinoma and borderline lesions: Demonstration by color Doppler imaging (2002) (7)
- Real-world virological efficacy and safety of daclatasvir/asunaprevir/beclabuvir in patients with chronic hepatitis C virus genotype 1 infection in Japan (2019) (7)
- Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy (2021) (7)
- Radiofrequency ablation for hepatocellular carcinoma: Clinical value of ultrasound–ultrasound overlay fusion for optimal ablation and local controllability (2020) (7)
- Health-Related Quality of Life (HRQOL) and Disease Symptoms in Patients with Unresectable Hepatocellular Carcinoma (HCC) Treated with Lenvatinib (LEN) or Sorafenib (SOR) (2017) (7)
- p38MAPK suppresses chronic pancreatitis by regulating HSP27 and BAD expression. (2012) (7)
- Clinical utility of treatment method conversion during single-session endoscopic ultrasound-guided biliary drainage (2020) (7)
- Cerebral vascular resistance in hepatic insufficiency (2001) (7)
- Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study (2013) (7)
- Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy. (2017) (7)
- New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma (2022) (7)
- Cecal Necrosis Due to Ischemic Colitis Mimicking an Abscess on Sonography (2006) (7)
- CD68-Positive Cells in Hepatic Angiomyolipoma (2016) (7)
- A randomized, double-blind, placebo-controlled phase III study of ramucirumab versus placebo as second-line treatment in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein following first-line sorafenib (REACH-2). (2016) (7)
- Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib (2022) (7)
- Consensus report from the 9th International Forum for Liver Magnetic Resonance Imaging: applications of gadoxetic acid-enhanced imaging (2021) (7)
- Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of Liver Cancer Study Group of Japan. (2015) (7)
- Association of Interleukin-28B and Hepatitis C Genotype 1 with a High Viral Load and Response to Pegylated Interferon plus Ribavirin Therapy (2011) (7)
- Advances in Liver Fibrosis Imaging and Hepatocellular Carcinoma: Update in 2013 (2013) (7)
- Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma (2011) (7)
- A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors (2022) (7)
- [Reversal of portal-systemic encephalopathy by shunt-preserving disconnection of portal and systemic circulation]. (1996) (7)
- Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma (2022) (7)
- Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma (2022) (7)
- A phase III, double-blind, randomized study of nivolumab (NIVO) and ipilimumab (IPI), nivo monotherapy or placebo plus transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC). (2021) (7)
- GS-09-Ramucirumab for patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: Outcomes by liver disease aetiology from two randomised, placebo-controlled phase 3 studies (REACH-2 and REACH) (2019) (7)
- A new type of hypoglycaemia in a newborn infant (1973) (7)
- Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2 (2016) (7)
- Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis (2021) (7)
- CD34 Expression in Noncancerous Liver Tissue Predicts Multicentric Recurrence of Hepatocellular Carcinoma (2013) (7)
- Clinical and Histological Features of Different Types of Budd-Chiari Syndrome: A Comparison of 4 Cases (2013) (7)
- Clinicopathological analysis of hepatic immune-related adverse events in comparison with autoimmune hepatitis and graft-versus host disease (2021) (7)
- 98 Prospective Multicenter Randomized Controlled Trial of Histological Diagnostic Yield Comparing 25G EUS-FNA Needles With and Without a Core Trap in Patients With Solid Pancreatic Masses (2014) (7)
- P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment (2020) (7)
- Multiple tuberculous abscesses of the liver and the brain in a patient with acute leukemia (2003) (7)
- Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese Population (2015) (7)
- Dynamic imaging of pancreatic tumors by contrast-enhanced harmonic EUS with long-lasting contrast (2009) (7)
- Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation (2003) (6)
- Erythropoietic Protoporphyria-related Hepatopathy Successfully Treated with Phlebotomy (2018) (6)
- Electronic hydraulic lithotripsy by antegrade digital cholangioscopy through endoscopic ultrasound-guided hepaticojejunostomy (2017) (6)
- Clinical tracing of small hypovascular hepatic nodules associated with chronic liver disease. (1994) (6)
- COMPUTER-AIDED DIAGNOSIS (CAD) BASED ON CONVOLUTIONAL NEURAL NETWORK (CNN) SYSTEM USING ARTIFICIAL INTELLIGENCE (AI) FOR COLORECTAL POLYP CLASSIFICATION (2019) (6)
- Hepaticogastrostomy guided by real-time contrast-enhanced harmonic endoscopic ultrasonography: a novel technique (2016) (6)
- Radiofrequency ablation therapy under harmonic imaging guidance for the recurring cancer after local therapy for HCC: a randomized controlled study with RFA under B-mode guidance (2003) (6)
- Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology (2021) (6)
- Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites (2021) (6)
- [Gastric ulcer, duodenal ulcer]. (2015) (6)
- Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study (2022) (6)
- Imaging findings of biliary hamartomas (von Meyenburg complexes) (2005) (6)
- Combination Immunotherapy with Anti-PD-1/PD-L1 Antibody plus Anti-VEGF Antibody May Promote Cytotoxic T Lymphocyte Infiltration in Hepatocellular Carcinoma, Including in the Noninflamed Subclass (2022) (6)
- EUS-guided in vivo microdialysis of the pancreas: a novel technique with potential diagnostic and therapeutic application. (2009) (6)
- Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study (2017) (6)
- Recent Trends in the Management of Hepatocellular Carcinoma with Special Emphasis on Treatment with Regorafenib and Immune Checkpoint Inhibitors (2016) (6)
- Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT (2021) (6)
- Outcome of Asunaprevir/Daclatasvir Combination Therapy for Chronic Liver Disease Type C (2016) (6)
- PIVKA-II is a predictive marker in the treatment response of sorafenib to hepatocellular carcinoma (2010) (6)
- Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy (2013) (6)
- Sequential treatment with sorafenib (SOR) followed by regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (HCC): Interim analysis of the observational REFINE study. (2020) (6)
- Expression of E-Cadherin and Vascular Endothelial Growth Factor in Noncancerous Liver Is Associated with Recurrence of Hepatocellular Carcinoma after Curative Resection (2013) (6)
- Abstract CT284: Phase 3 KEYNOTE-937: Adjuvant pembrolizumab versus placebo in patients with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation (2020) (6)
- Regorafenib in patients with unresectable hepatocellular carcinoma (uHCC) in routine clinical practice: Interim analysis of the prospective, observational REFINE trial. (2020) (6)
- Natural Course of Small Nodular Lesions with Intranodular Preserved Portal Supply in Cirrhotic Liver (2007) (6)
- A Social Program for the Early Detection of Pancreatic Cancer: The Kishiwada Katsuragi Project (2017) (6)
- Case of rapidly progressed sarcomatoid hepatocellular carcinoma in a young female without risk factor (2007) (6)
- A case with hepatic immune-related adverse events caused by nivolumab exhibiting impaired accumulation of regulatory T cells (2021) (6)
- Contrast-enhanced agent detection imaging: Early experience in hepatocellular carcinoma (2003) (6)
- Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation (2021) (6)
- The IFN-α-IL-33 Axis as Possible Biomarkers in IgG4-Related Disease. (2019) (6)
- OPTIMIS: An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). (2014) (6)
- Virtual Sonography for Novice Sonographers: Usefulness of SYNAPSE VINCENT® with Pre-Check Imaging of Tumor Location (2014) (6)
- Adjuvant therapy after radical surgery for hepatocellular carcinoma: still an unmet need. (2019) (6)
- Endoscopic ultrasonography‐guided choledochoduodenostomy using a newly designed laser‐cut metal stent: Feasibility study in a porcine model (2017) (6)
- Phase 3, randomized study of pembrolizumab (pembro) vs best supportive care (BSC) for second-line advanced hepatocellular carcinoma (HCC): KEYNOTE-240. (2017) (6)
- Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib (2022) (6)
- G06 : A randomized, double-blind, placebo-controlled phase III trial of TSU-68 (orantinib) combined with transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma (2015) (6)
- Gastrointestinal tumors, non-colorectal (2012) (6)
- [Hepatic receptor imaging with Tc-99m GSA: estimates of liver function in acute liver disease]. (1992) (6)
- Nivolumab + ipilimumab combination therapy in patients with advanced hepatocellular carcinoma: subgroup analyses from CheckMate 040 (2020) (6)
- Cone-Beam CT Angiography for Hepatocellular Carcinoma: Current Status (2015) (6)
- Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer. (2019) (6)
- Induction of Complete Remission by Azacitidine in a Patient with Myelodysplastic Syndrome-Associated Inflammatory Bowel Disease. (2018) (6)
- The Draining Vessel of Advanced Hepatocellular Carcinoma: Assessment of Color Doppler Findings in Comparison with Histopathological Findings. (1999) (5)
- RESORCE: An ongoing randomized, double-blind, phase III trial of regorafenib (REG) in patients with hepatocellular carcinoma (HCC) progressing on sorafenib (SOR). (2014) (5)
- Double-Filtration Plasmapheresis plus IFN for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy: Early Viral Dynamics (2010) (5)
- Primary Sclerosing Cholangitis and Hepatitis C Virus Infection (2005) (5)
- Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report (2020) (5)
- ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240 (2021) (5)
- P-61 Relatlimab + nivolumab in patients with advanced hepatocellular carcinoma who are naive to immuno-oncology therapy but progressed on tyrosine kinase inhibitors, a phase 2, randomized, open-label study: RELATIVITY-073 (2021) (5)
- Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. (2022) (5)
- Well-differentiated HCC manifesting hyperattenuation on CT during arterial portography. (2005) (5)
- A case of well‐differentiated minute hepatocellular carcinoma with extrahepatic metastasis (1998) (5)
- In vivo quantification of asialoglycoprotein receptor. (1994) (5)
- Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma (2021) (5)
- Autoimmune thrombocytopenic purpura during pegylated interferon α treatment for chronic hepatitis C. (2010) (5)
- Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone (2020) (5)
- Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results (2003) (5)
- A study on liver tumor detection from an ultrasound image using deep learning (2020) (5)
- Successful biliary cannulation using a novel rotatable sphincterotome in a patient with situs inversus totalis (2020) (5)
- Practice patterns and deterioration of liver function after transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): Final analysis of OPTIMIS in Europe and Canada. (2018) (5)
- O-6 The novel regimen of tremelimumab in combination with durvalumab provides a favorable safety profile and clinical activity for patients with advanced hepatocellular carcinoma (2020) (5)
- Emerging Strategies for the Management of Hepatocellular Carcinoma (2014) (5)
- Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (HCC): Phase II KEYNOTE-224 study. (2021) (5)
- Avid accumulation of Ga-67 citrate in adenocarcinoma of pancreas. (1989) (5)
- Efficacy and safety of ramucirumab (RAM) for advanced hepatocellular carcinoma (HCC) with elevated alpha-fetoprotein (AFP) following first-line sorafenib across age subgroups in two global phase III trials (REACH and REACH-2) (2019) (5)
- Detection of High-Grade Pancreatic Intraepithelial Neoplasia without Morphological Changes of the Main Pancreatic Duct over a Long Period: Importance for Close Follow-Up for Confirmation (2017) (5)
- Sonographic findings of wandering spleen (2001) (5)
- Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study (2017) (5)
- Endoscopic ultrasound-guided pancreaticogastrostomy reconstruction. (2007) (5)
- 1016TiP LEAP-012 trial in progress: Pembrolizumab plus lenvatinib and transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma (HCC) not amenable to curative treatment (2020) (5)
- Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study (2021) (5)
- Hepatocellular carcinoma and NASH (2004) (5)
- Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis. (2022) (5)
- Hepatocellular carcinoma and NASH (2004) (5)
- Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease (2021) (5)
- Synchronous pancreatic and gastric metastasis from an ovarian adenocarcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration (2015) (5)
- P933 ONCE-DAILY ORAL LUSUTROMBOPAG, ALTERNATIVE TO PLATELET TRANSFUSION IN THROMBOCYTOPENIC PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING RADIOFREQUENCY ABLATION: RESULTS FROM A PHASE 2B, RANDOMIZED, DOUBLE-BLIND STUDY (2014) (5)
- Well-to moderately-differentiated HCC manifesting hyperattenuation on both CT during arteriography and arterial portography. (2007) (5)
- Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25]. (2018) (5)
- IMbrave150: updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC) (2021) (5)
- Viral Hepatitis and Hepatocellular Carcinoma: Update in 2012 (2012) (5)
- 81 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB) STUDY FIRST INTERIM RESULTS: SORAFENIB DOSING ACROSS REGIONS AND DISEASE SUBGROUPS (2011) (5)
- Dynamic Imaging By Contrast-Enhanced Harmonic EUS with Long-Lasting Contrast: Role in Diagnosis of Pancreatic Tumors (2009) (5)
- Dual‐frequency MR elastography to differentiate between inflammation and fibrosis of the liver: Comparison with histopathology (2020) (5)
- Better Efficacy of Ramucirumab in Japanese Patients than in the Global Population with Unresectable Hepatocellular Carcinoma (2020) (5)
- Phase III study of pembrolizumab (pembro) versus best supportive care (BSC) for second-line therapy in advanced hepatocellular carcinoma (aHCC): KEYNOTE-240 Asian subgroup. (2020) (5)
- Navigator-triggered and breath-hold 3D MRCP using compressed sensing: image quality and method selection factor assessment (2020) (5)
- Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy (2011) (5)
- EUS-Guided Pancreatic Duct Drainage for Repeat Pancreatitis in a Patient with Pancreatic Cancer (2017) (5)
- Purpura-free small intestinal IgA vasculitis complicated by cytomegalovirus reactivation (2020) (5)
- Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL) (2019) (5)
- P0372 : Gideon: A retrospective analysis of prognostic factors for survival (2015) (5)
- Value of artificial intelligence with novel tumor tracking technology in the diagnosis of gastric submucosal tumors by contrast‐enhanced harmonic endoscopic ultrasonography (2022) (5)
- 1008P IMbrave150: Management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC (2020) (5)
- The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment (2020) (5)
- [Systemic therapy for hepatocellular carcinoma:recent advances and future perspective]. (2019) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection (2022) (4)
- Pembrolizumab vs best supportive care for second-line advanced hepatocellular carcinoma: Randomized, phase 3 KEYNOTE-240 study (2016) (4)
- 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment (2015) (4)
- Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks (2010) (4)
- Chronic Liver Diseases and Liver Cancer: An Update in 2015 (2015) (4)
- Evaluation of therapeutic response to gemcitabine in pancreatic cancer. (2008) (4)
- Comparison of radiation exposure between endoscopic ultrasound‐guided drainage and transpapillary drainage by endoscopic retrograde cholangiopancreatography for pancreatobiliary diseases (2021) (4)
- A case of localized primary sclerosing cholangitis mimicking intrahepatic bile duct cancer. (2001) (4)
- Endoscopic findings of intestinal Behçet's disease complicated with toxic megacolon. (2010) (4)
- Gastric Perineurioma (2016) (4)
- Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease (2016) (4)
- Hepatocellular carcinoma that ruptured during radiofrequency ablation therapy (2004) (4)
- A case of successful transluminal drainage of walled-off necrosis under contrast-enhanced harmonic endoscopic ultrasonography guidance (2017) (4)
- Adriamycin Enhances Proteasome-Mediated Generation of the Proapoptotic Processed Form of MAGE-A4 in Hepatoma Cells (2011) (4)
- International comparison of treatment outcomes based on staging systems (2007) (4)
- Complete responses (CR) in patients receiving atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in IMbrave150: A phase III clinical trial for unresectable hepatocellular carcinoma (HCC). (2020) (4)
- Transcatheter endoscopy for pancreaticobiliary duct diseases (with videos). (2012) (4)
- LBA17RANDOMISED STUDY OF AXITINIB (AXI) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO (PBO) PLUS BSC IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) FOLLOWING PRIOR ANTIANGIOGENIC THERAPY (2014) (4)
- Current status of endoscopic re‐intervention for hilar malignant biliary obstruction (2021) (4)
- Coffee Intake and Liver Enzyme Association in Korean Immigrants and Japanese: A Comprehensive Cross-Sectional Study (2016) (4)
- Gastric Inverted Hyperplastic Polyp Mimicking a Papilla (2018) (4)
- Primary Hepatic Adenosquamous Carcinoma Associated with Primary Sclerosing Cholangitis (2017) (4)
- Optimal cropping for input images used in a convolutional neural network for ultrasonic diagnosis of liver tumors (2020) (4)
- Quantification of tumor vascularity with contrast-enhanced ultrasound for early response of transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of three cases (2011) (4)
- Challenges of Clinical Research on Hepatocellular Carcinoma (2015) (4)
- Radiofrequency Ablation Guided by Contrast-Enhanced Sonography versus B-Mode Sonography for Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization (2016) (4)
- 115 Improved Diagnosis of Liver Metastases Using Kupffer-Phase Image of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in Patients With Pancreatic Cancer (2017) (4)
- Vascularity of advanced gastric carcinoma: Evaluation by using power Doppler imaging (2001) (4)
- Small hepatocellular carcinoma presenting with massive metastasis in the peritoneum, mimicking sarcomatous tumor (2007) (4)
- Contrast-Enhanced Tissue Harmonic Imaging versus Phase Inversion Harmonic Sonographic Imaging for the Delineation of Hepatocellular Carcinomas (2016) (4)
- Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis (2016) (4)
- 73P Long-term follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer (2020) (4)
- Atezolizumab plus Bevacizumab versus Sorafenib for Unresectable Hepatocellular Carcinoma: Results from Older Adults Enrolled in the IMbrave150 Randomized Clinical Trial (2022) (4)
- A phase I, open-label, multi-center, dose-escalation study of codrituzumab, an anti-glypican-3 monoclonal antibody, in combination with atezolizumab in patients with locally advanced or metastatic hepatocellular carcinoma. (2018) (4)
- Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease (2021) (4)
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH‐HCC Guidelines) (2023) (4)
- Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version) (2022) (4)
- 1017TiP KEYNOTE-937 trial in progress: adjuvant pembrolizumab in patients with hepatocellular carcinoma (HCC) and complete radiologic response after surgical resection or local ablation (2020) (4)
- Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis (2022) (4)
- Cumulative radiation doses from recurrent PET–CT examinations (2021) (4)
- Endoscopic Reintervention for Recurrence of Malignant Biliary Obstruction: Developing the Best Strategy (2022) (4)
- MIXED INTESTINAL‐ AND DIFFUSE‐TYPE HISTOLOGY IS A RISK FACTOR FOR LYMPH NODE METASTASIS OF SUBMUCOSAL INVASIVE GASTRIC CANCER (2007) (4)
- Efficacy of Over-The-Scope Clip Method as a Novel Hemostatic Therapy for Colonic Diverticular Bleeding (2021) (4)
- Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2 (2016) (4)
- Endoscopic findings can predict the efficacy of leukocytapheresis for steroid-naive patients with moderately active ulcerative colitis. (2008) (4)
- Prospective Risk Analysis of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C by Ultrasound Strain Elastography (2016) (4)
- Hepatocellular Carcinoma 2009 and Beyond (2009) (4)
- Efficacy and Safety of Telaprevir-Based Antiviral Treatment for Elderly Patients with Hepatitis C Virus (2014) (4)
- Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial. (2021) (4)
- A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis (2017) (4)
- Tu1344 VALUE OF CONTRAST-ENHANCED HARMONIC EUS WITH ENHANCEMENT PATTERN FOR DIAGNOSIS OF PANCREATIC CANCER: A META-ANALYSIS (2019) (4)
- Scintigraphic study of regenerative nodules due to fulminant hepatic failure (2003) (4)
- Evaluation of asialoglycoprotein receptor-binding, synthetic radiolabeled glycoprotein in estimating hepatic functional reserve. (1987) (4)
- Analysis of Progression Time in Pancreatic Cancer including Carcinoma In Situ Based on Magnetic Resonance Cholangiopancreatography Findings (2021) (4)
- Asian Pacific Association for Study of the Liver (APASL) (2003) (4)
- Abdominal Ultrasound Findings of Tumor-Forming Hepatic Malignant Lymphoma (2017) (4)
- Acute Pancreatitis with Disturbed Consciousness Caused by Hyperparathyroidism (2018) (4)
- Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH). (2019) (4)
- Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2 (2017) (4)
- Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C with High Viral Load of Serum Hepatitis C Virus RNA, Genotype 1b, Discontinued on Attaining Sustained Virological Response at Week 16 after Onset of Acute Pancreatitis (2009) (4)
- Hepatic nodules associated with an inferior mesentric arteriovenous malformation. (2012) (4)
- Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab (2022) (4)
- Gankyrin Contributes to Tumorigenesis and Chemoresistance in Sporadic Colorectal Cancer (2018) (4)
- FRI-499-Efficacy and hepatic safety of nivolumab treatment in patients with Child-Pugh B disease and advanced hepatocellular carcinoma in CheckMate 040 (2019) (4)
- Measurement of functioning hepatocyte mass via [99mTc]galactosyl-neoglycoalbumin (1993) (4)
- Neuroendocrine tumors and CUP (2012) (4)
- Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma? (2021) (4)
- Analysis of Patient Outcome after Non-curative Resection for Hepatocellular Carcinoma Using Nationwide Survey Data in Japan (2020) (4)
- Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study. (2020) (4)
- IL-33 as a Critical Cytokine for Inflammation and Fibrosis in Inflammatory Bowel Diseases and Pancreatitis (2021) (4)
- Improved survival in patients with hepatocellular carcinoma over 30 years in Japan: Analysis of nationwide prospective registry of 148,161 patients. (2011) (3)
- Sorafenib treatment by Child-Pugh score in Latin American patients with hepatocellular carcinoma. (2020) (3)
- 937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD (2021) (3)
- FRI-494-Practice patterns and outcomes of transarterial chemoembolization in patients with hepatocellular carcinoma who were ineligible and eligible for transarterial chemoembolization at inclusion: Global OPTIMIS exploratory analysis (2019) (3)
- 1010P Real-world dosing of regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Interim analysis (IA) of the observational REFINE study (2020) (3)
- Bile duct adenoma in patient with chronic hepatitis C: As a benign neoplasm by pathological and imaging studies (2016) (3)
- Unusual hepatocellular carcinoma with macroscopic biliary tumor thrombus accompanied by rim calcification and no arterial-phase enhancement (2008) (3)
- [Recurrent hepatocellular carcinoma]. (2013) (3)
- Foreword to the WFUMB guidelines and recommendations on the clinical use of ultrasound elastography. (2015) (3)
- Pembrolizumab in patients with previously treated advanced hepatocellular carcinoma: Phase 2 KEYNOTE-224 study (2016) (3)
- Large balloon expansion method for re‐intervention after endoscopic ultrasound‐guided hepaticogastrostomy for stent obstruction (2019) (3)
- Early Viral Response Predicts the Efficacy of Antiviral Triple Therapy with Simeprevir, Peg-Interferon and Ribavirin in Patients Infected with Hepatitis C Virus Genotype 1 (2015) (3)
- Bispectral index-guided propofol sedation during endoscopic ultrasonography (2022) (3)
- Sorafenib versus hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma: A Japanese multi-center large cohort study. (2019) (3)
- Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals (2017) (3)
- 1249 Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: analysis of 3,891 ablations in 2,614 patients (2003) (3)
- Novel Mouse Models of Hepatocarcinogenesis with Stepwise Accumulation of Genetic Alterations (2013) (3)
- Hepatic angiomyolipoma: identification of an efferent vessel as a hepatic vein by contrast-enhanced harmonic sonography (2005) (3)
- [Occurrence of angioimmunoblastic T-cell lymphoma six months after onset of Lyme disease]. (2000) (3)
- Intraperitoneal application of caffeine prevents D-galactosamine- induced hepatic expression of connective tissue growth factor (CTGF/CCN2) in the rat (2009) (3)
- Prognostic and predictive role of circulating angiopoietin-2 in multiple solid tumors: An analysis of approximately 500 patients treated with lenvatinib across tumor types. (2014) (3)
- Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade (2016) (3)
- Epigenetic regulation and development of hepatocellular carcinoma. (2016) (3)
- Sorafenib treatment and safety profile in Child Pugh B patients characterized in first interim results of GIDEON (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib) (2011) (3)
- Prevention of Delayed Bleeding After Endoscopic Submucosal Dissection (ESD) for Gastric Tumors (2011) (3)
- Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration (2021) (3)
- Multiple metastases from a meningeal hemangiopericytoma associated with severe hypoglycemia (2005) (3)
- Pattern of progression in advanced HCC treated with ramucirumab/placebo: Results from two randomized phase III trials (REACH/REACH-2). (2020) (3)
- [Molecular targeted therapy for advanced hepatocellular carcinoma]. (2009) (3)
- Phase I/II study of CPT-11 plus S-1 in patients with advanced gastric cancer. (2004) (3)
- Novel concept using a plastic stent for endoscopic ultrasound-guided hepaticogastrostomy adjusting the length according to the patient’s anatomy (2019) (3)
- Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2 (2017) (3)
- Foreign body granuloma mimicking disseminated tumour recurrence after radiofrequency ablation for hepatocellular carcinoma (2008) (3)
- Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment (2022) (3)
- Regional differences in efficacy/safety/biomarkers in a randomised study of axitinib in 2nd line patients (pts) with advanced hepatocellular carcinoma (HCC). (2016) (3)
- 219O Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study (2016) (3)
- The radiation doses and radiation protection on the endoscopic retrograde cholangiopancreatography procedures. (2021) (3)
- Correlation between Insulin Resistance and Outcome of Pegylated Interferon and Ribavirin Therapy, Hepatic Steatosis, Hepatic Fibrosis in Chronic Hepatitis C-1b and High Viral Load (2011) (3)
- Hepatobiliary and pancreatic: Arterioportal fistula causing portal hypertension (2003) (3)
- 11 – Hepatic Receptor Imaging Using Radiolabeled Asialoglycoprotein Analogs (1994) (3)
- Intestinal Dysbiosis and Autoimmune Pancreatitis (2021) (3)
- Artificial intelligence-based endoscopic diagnosis of colorectal polyps using residual networks (2021) (3)
- Initial Experience Performing Percutaneous Ultrasound Examination with Real-Time Virtual Sonography with Color Display (2015) (3)
- Novel Non-Trocar Technique for Laparoscopic Radiofrequency Ablation (2012) (3)
- Single HCC between 2 and 5 cm: the grey zone (2010) (3)
- Properties of Levovist (2003) (3)
- Stress Response Protein RBM3 Promotes the Development of Colitis-associated Cancer (2017) (3)
- Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota (2020) (3)
- Promising anticancer therapy: combination of immune checkpoint inhibitors and molecular-targeted agents. (2020) (3)
- Tailor-Made Therapy for Viral Hepatitis: Recent Advances (2011) (3)
- Sorafenib plus intra-arterial cisplatin versus sorafenib alone in patients with advanced hepatocellular carcinoma: A randomized phase II trial. (2015) (3)
- Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (2022) (3)
- Assessment of image quality of contrast-enhanced power doppler imaging in hepatocellular carcinoma with the personal ultrasound imager: Comparison with the conventional machine (2003) (3)
- [In vivo measurement of hepatic binding protein in chronic liver disease--validation as a measure of hepatic functional reserve]. (1991) (3)
- Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma (2022) (3)
- Endoscopic sclerotherapy under balloon-assisted enteroscopy for hemorrhagic jejunal varices after choledocho-jejunostomy (2019) (3)
- Response Evaluation Criteria in Cancer of the Liver version 6 (RECICL 2021 Revised Version). (2022) (3)
- Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis (2017) (3)
- A novel technique for stent dysfunction after endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting (2019) (3)
- Severe Immune-Related Hepatitis Treated With Plasma Exchange. (2020) (3)
- [Clinical utility of receptor imaging in the assessment of liver function]. (1992) (3)
- Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240. (2020) (3)
- Septicemia due to Vibrio cholerae serogroup non-O1/non-O139 strain in a cirrhotic patient (2012) (3)
- Sa1434 Contrast Enhanced Harmonic EUS Imaging of Submucosal Tumor of Gastrointestinal Tract (2011) (2)
- Utility and Safety of a Novel Fully Covered Metal Stent in Unresectable Distal Malignant Biliary Obstruction (2020) (2)
- 371 The Oncoprotein Gankyrin Links Inflammation and Tumorigenesis in Inflammatory Bowel Disease (2016) (2)
- WEGENER’S GRANULOMATOSIS COMPLICATED WITH APHTHOID COLITIS (2006) (2)
- 348 Role of Contrast-Enhanced Harmonic EUS in Differentiating Malignant From Benign Lymphadenopathy (2013) (2)
- Probiotic-Derived Polyphosphate Prevents Pancreatitis (2021) (2)
- Regorafenib (REG) in patients with hepatocellular carcinoma (HCC) progressing following sorafenib: An ongoing randomized, double-blind, phase III trial. (2013) (2)
- Comparison of the Diagnostic Performance of Newly Designed 21-Gauge and Standard 22-Gauge Aspiration Needles in Patients with Solid Pancreatic Masses (2019) (2)
- Multistep progression from a hypovascular nodule to a nodule-in-nodule type hepatocellular carcinoma in hepatitis C-related cirrhosis. (2008) (2)
- Abstract 485: Early antibiotic exposure delays disease progression following immune checkpoint inhibitor therapy for hepatocellular carcinoma: Evidence from an observational study (2021) (2)
- Efficacy and safety of nivolumab in patients with advanced hepatocellular carcinoma analyzed by patient age: A sub-analysis of the CheckMate 040 study. (2017) (2)
- Breakthroughs in the Management of Hepatocellular Carcinoma: Celebrating 50 Years of the Liver Cancer Study Group of Japan (2014) (2)
- Hemorrhage from metastasis of a 5-mm renal cell carcinoma lesion to the gallbladder detected by contrast-enhanced endoscopic ultrasonography. (2019) (2)
- Sa1661 Effect of Rebamipide for Endoscopic Submucosal Dissection (ESD) -Induced Ulcer in Early Gastric Cancer: A Randomized Controlled Trial (2012) (2)
- Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: An international study. (2022) (2)
- Assessment of Hepatic Fibrosis With Real-Time Tissue Elastography in Chronic Viral Hepatitis (2013) (2)
- Lack of response to immunotherapy in non-alcoholic steatohepatitis related hepatocellular carcinoma. (2021) (2)
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion: A Japanese nationwide survey. (2016) (2)
- Identification of a high-response patient population to S-1 via predictive enrichment strategy analysis of the S-CUBE phase III trial. (2016) (2)
- 714P Impact of viral aetiology in the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022) (2)
- Peginterferon ALPHA-2A (40KD) Plus Ribavirin for the Treatment of Patients With Chronic Hepatitis C (CHC) and Compensated Liver Cirrhosis in Japan (2011) (2)
- Hemodynamic and morphologic changes of peripheral hepatic vasculature in chronic liver disease: a preliminary study by contrast-enhanced coded phase-inversion harmonic sonography (2005) (2)
- Phase Ib dose-escalation study of a phase II randomized trial to assess the safety and tolerability of tigatuzumab (CS-1008) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC). (2012) (2)
- Overall Survival (OS) Update: 2-year follow-up from the phase-3 RESORCE trial of Regorafenib for patients with hepatocellular carcinoma (HCC) progressing on Sorafenib (2019) (2)
- Phase II clinical study of combination therapy with irinotecan and S-1(IRIS) for inoperable recurrent advanced colorectal cancer: Hokkaido Gastrointestinal Cancer Study Group study HGCSG-0302). (2006) (2)
- IMbrave150: Efficacy and Safety of Atezolizumab Plus Bevacizumab vs Sorafenib in Patients With Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma—An Exploratory Analysis of the Phase III Study (2022) (2)
- Cystic duct antegrade stenting for cholangitis after the long-term deployment of lumen-apposing metal stents for calculous cholecystitis (2018) (2)
- Cabozantinib for advanced hepatocellular carcinoma. (2019) (2)
- Successful use of two guidewires with different properties using a double-lumen catheter for postoperative biliary stricture (2021) (2)
- Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance (2013) (2)
- Efficacy of EUS-guided celiac plexus neurolysis in combination with EUS-guided celiac ganglia neurolysis for pancreatic cancer-associated pain: a multicenter prospective trial (2022) (2)
- Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study (2016) (2)
- Final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with sorafeNib) in > 3000 sorafenib-treated patients: Prognostic value of baseline characteristics and staging systems (2013) (2)
- SY1. building the foundation for investigator-initiated clinical trial (2012) (2)
- Repeated hepatic arterial chemoembolization therapy for management of a patient with metastatic carcinoid tumors of the liver (2000) (2)
- Diagnosis of acute cholecystitis in patients with liver cirrhosis: waveform analysis of the cystic artery by color Doppler imaging (2004) (2)
- Sa1910 Time Trends for Helicobacter pylori Eradication Rate of the First-Line and Second-Line Japanese Regimens and Clarithromycin Resistance (2013) (2)
- Impact of hepatitis C virus on survival in patients undergoing resection of intrahepatic cholangiocarcinoma: Report of a Japanese nationwide survey (2021) (2)
- Safety and efficacy of lenvatinib by starting dose (8 mg or 12 mg) based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT. (2019) (2)
- Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (2)
- Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): Second interim analysis of the Global Investigation of Therapeutic Decisions in HCC and of Its Treatment with Sorafenib (GIDEON) study. (2012) (2)
- Nivolumab (Nivo) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): the CheckMate 040 Study (2016) (2)
- Risk of Hepatocellular Carcinoma Development in Cases of Hepatitis C Treated by Long-Term, Low-Dose PEG-IFNα-2a (2012) (2)
- Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240 (2019) (2)
- Cannulation method for intradiverticular papilla with long oral protrusion using biopsy forceps for axis alignment (2018) (2)
- RECIST v1.1 and irRECIST outcomes in advanced HCC treated with pembrolizumab (pembro). (2020) (2)
- Detection and Tracking of Liver Tumors for Ultrasound Diagnostic Support Using Deep Learning (2022) (2)
- Subsequent anticancer procedures following first-line lenvatinib (LEN): A post hoc analysis from the phase III REFLECT study in unresectable hepatocellular carcinoma (uHCC). (2020) (2)
- The 4th Asia-Pacific Primary Liver Cancer Expert Meeting (2013) (2)
- Diagnostic Value of EUS-Guided Fine-Needle Aspiration Biopsy for Gastric Linitis Plastica with Negative Endoscopic Biopsy (2021) (2)
- Intracystic papillary neoplasm preoperatively diagnosed by high-quality cytology derived from endoscopic nasogallbladder drainage. (2019) (2)
- SO-12 Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients with advanced hepatocellular carcinoma (aHCC): 5-year results from CheckMate 040 (2022) (2)
- REPLACEMENT trial in progress: Combination therapy with atezolizumab plus bevacizumab for TACE unsuitable patients with beyond up-to-seven criteria in intermediate stage hepatocellular carcinoma: A phase II study. (2021) (2)
- Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study. (2022) (2)
- A case of small invasive gastric cancer arising from Helicobacter pylori‐negative gastric mucosa: Fundic gland‐type adenocarcinoma (2017) (2)
- 1264 Changes of agglutinin-reactive alpha-fetoprotein (AFP-L3 fraction) after complete radiofrequency ablation for hepatocellular carcinoma: analysis of 186 patients (2003) (2)
- Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load (2013) (2)
- Utility of contrast-enhanced harmonic EUS for evaluating the effects of steroid therapy in a case of immunoglobulin G4-negative focal autoimmune pancreatitis. (2017) (2)
- Endoscopic ultrasound-guided choledochoduodenostomy with novel use of contrast-enhanced harmonic imaging (2017) (2)
- Neurilemmoma Mimicking a Multilocular Cystic Lesion of the Liver (2018) (2)
- Abstract CT009: IMbrave150: Updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC) (2021) (2)
- O-005Ramucirumab (RAM) as second-Line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib: comprehensive results from the randomized phase III REACH study (2015) (2)
- Rendezvous within biloma technique combining percutaneous and endoscopic approaches: a novel biliary recanalization method (2018) (2)
- Viral Hepatitis A to E: An Update in 2010 (2010) (2)
- Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome (PFO) results from the phase 3 REACH study. (2015) (2)
- HCC BRIDGE study : BRIDGE to better outcomes in hepatocellular carcinoma (2009) (2)
- A new era of systemic therapy for intermediate and advanced stage hepatocellular carcinoma. (2020) (2)
- Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma (2019) (2)
- Senile systemic amyloidosis localized to the stomach (2013) (2)
- Concept of the clinical stages of acute hepatic failure. (1986) (2)
- Semiquantitative prediction of early response of conventional transcatheter arterial chemoembolization for hepatocellular carcinoma using postprocedural plain cone‐beam computed tomography (2017) (2)
- Achievement of long-term stent patency in endoscopic ultrasonography-guided right bile duct drainage after left hepatic lobectomy (with video) (2017) (2)
- Endoscopic submucosal dissection of duodenal adenocarcinoma arising from Brunner’s gland (2019) (2)
- FGF3/FGF4 Amplification and Multiple Lung Metastases in Responders to Sorafenib in Hepatocellular Carcinoma (2013) (2)
- Possible involvement of autophagy in esophageal ulcers in anorexia nervosa (2020) (2)
- Achievement of Complete Response and Drug-free Status by Atezolizumab Plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-stage Hepatocellular Carcinoma: A Multicenter Proof-of-Concept Study (2023) (2)
- Across-the-papilla side-by-side placement of 6-mm fully covered metallic stents for malignant hilar biliary obstruction: a novel concept that may facilitate reintervention (2021) (2)
- Retreatment with Peginterferon α-2a + Ribavirin in Patients Who Failed Previous Peginterferon α-2b + Ribavirin Combination Therapy (2012) (2)
- Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis (2019) (2)
- Safety and Efficacy of amplitude-modulated radiofrequency electromagnetic fields in advanced hepatocellular carcinoma (2021) (2)
- Utility of contrast-enhanced harmonic endoscopic ultrasonography for T-staging of patients with extrahepatic bile duct cancer (2021) (2)
- Improved Tumor Response to Lenvatinib Re-Treatment after Failure of Immune Checkpoint Inhibitors in a Patient with Advanced Hepatocellular Carcinoma (2021) (2)
- Usefulness of the Novel Snare-over-the-Guidewire Method for Transpapillary Plastic Stent Replacement (with Video) (2021) (2)
- Corrigendum to: “Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey” [J Hepatol 2013;58:724–729] (2013) (2)
- Modified single transluminal gateway transcystic multiple drainage technique for a huge infected walled-off pancreatic necrosis: A case report. (2016) (2)
- Current Perspectives on the Immunosuppressive Niche and Role of Fibrosis in Hepatocellular Carcinoma and the Development of Antitumor Immunity (2021) (2)
- DIAGNOSTIC VALUE OF LIVER SCINTIGRAPHY, COMPUTED TOMOGRAPHY AND ULTRASONOGRAPHY OF ACUTE HEPATITIS (1984) (2)
- Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C (2017) (2)
- Recurrent abdominal pain caused by nephroptosis (2020) (2)
- Author response to: Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma (2020) (2)
- Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study. (2021) (2)
- [Current status of radiation exposure to crystalline lens in ERCP (endoscopic retrograde cholangiopancreatography)]. (2019) (2)
- Transarterial infusion chemotherapy alone versus transarterial chemoembolization for the treatment of hepatocellular carcinoma: Results of a multicenter randomized phase III trial (2007) (1)
- P1338 : An international observational study to assess the use of sorafenib after transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC): optimis (2015) (1)
- [Clinical and histological study on prognosis of patients survived from acute hepatic failure. Investigation of 6 cases and review of literature (author's transl)]. (1981) (1)
- Exploratory circulating biomarker analyses: lenvatinib + pembrolizumab (L + P) in a phase 1b trial in unresectable hepatocellular carcinoma (uHCC). (2021) (1)
- Transverse colonic volvulus due to mesenteric fibromatosis: a case report (2021) (1)
- Intrahepatic portal-hepatic venous shunt with portal aneurysmal dilatation diagnosed by color Doppler imaging. Report of two cases. (1992) (1)
- Rapid and extensive intrahepatic metastatic recurrence of hepatocellular carcinoma with very small portal vein tumor thrombus after surgery and sustained virological response of HCV with direct‐acting antivirals (2019) (1)
- Impact of baseline hepatitis B viremia and management on outcomes in advanced hepatocellular carcinoma and elevated alpha-fetoprotein: outcomes from REACH-2 (2020) (1)
- 775TiPKEYNOTE-240: Phase 3, randomized study of pembrolizumab (pembro) vs best supportive care (BSC) for second-line advanced hepatocellular carcinoma (HCC) (2017) (1)
- Tu1545 A Prospective Feasibility Study on EUS Guided Broad Plexus in Combination of Celiac Ganglion Neurolysis in Pancreatic Cancer Pain (2012) (1)
- Final Results of a Randomized Phase II Study of TSU-68 after Transarterial Chemoembolisation in Japanese Patients with Unresectable Hepatocellular Carcinoma.Chemoembolization (2012) (1)
- 1003P Baseline (BL) liver function and outcomes in patients (pts) with unresectable hepatocellular carcinoma (HCC) in KEYNOTE-240 (2020) (1)
- Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of REACH pts by Child-Pugh (CP) score. (2015) (1)
- Castor oil as booster for colon capsule endoscopy preparation reduction: A prospective pilot study and patient questionnaire (2021) (1)
- Conversion of percutaneous transhepatic gallbladder drainage to endoscopic ultrasound‐guided hepaticogastrostomy by the intentional expansion method (2019) (1)
- Objective response by mRECIST to predict survival in hepatocellular carcinoma: A multivariate, time-dependent analysis from the phase III BRISK-PS study. (2015) (1)
- Gastrointestinal tumors, colorectal (2012) (1)
- The status of polycystic liver disease in Japan: a questionnaire survey of patients (2011) (1)
- Novel sphincterotomy device that orientates blade along the axis of the bile duct in patients with Roux-en-Y anastomosis (2019) (1)
- P024 KEYNOTE-937 trial in progress: adjuvant pembrolizumab for hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation (2021) (1)
- Endoscopic nasobiliary drainage tube‐guided scope insertion technique for internal drainage in a case of difficult selective biliary duct guiding (2018) (1)
- Glasgow prognostic score predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib: a multicenter analysis (2022) (1)
- 699 OBSERVED PATTERNS OF SYSTEMIC THERAPY USE IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS FROM THE MULTINATIONAL HCC BRIDGE STUDY: RESULTS OF A SECOND INTERIM ANALYSIS (2012) (1)
- Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4. (2022) (1)
- Efficacy of an easy loop-forming guidewire in endoscopic transpapillary gallbladder drainage with gallstones impacted in the cystic duct (2022) (1)
- Atezolizumab + bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma: safety results from the Phase III IMbrave150 study (2020) (1)
- O-5 Efficacy and safety of nivolumab + ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study (2020) (1)
- [Home terminal care for terminal gastric cancer patients--case of epidural morphine injection]. (1994) (1)
- Intraarterial Contrast-Enhanced Ultrasonography Is the Final Goal of Intravenous Contrast-Enhanced Ultrasonography (2003) (1)
- C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib (2022) (1)
- T1437: EUS-Guided Choledochoduodenostomy Followed by Endoscopic Antegrade Biliary Stenting via the Fistula for Treatment of Obstructive Jaundice With Duodenal Stenosis (2010) (1)
- [Radio frequency ablation for metastatic liver cancer]. (2009) (1)
- Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C (2017) (1)
- Utility of contrast-enhanced harmonic EUS for diagnosis of portal vein invasion by pancreatic cancer (2022) (1)
- Chronic Liver Diseases and Liver Cancer: State-of-the Art Progress in 2016 (2016) (1)
- Independent imaging review (IIR) results in a phase 3 trial of lenvatinib (LEN) versus sorafenib (SOR) in first-line treatment of patients (pts) with unresectable hepatocellular carcinoma (uHCC). (2018) (1)
- Contrast-Enhanced Harmonic EUS: A Method to Visualize Microcirculation in Digestive Organs (2005) (1)
- A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses after COVID-19 Vaccination (2022) (1)
- Abstract 3406: Impact of TJP-1 and TWIST expression on post-operative prognosis in hepatocellular carcinoma (2012) (1)
- Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2) (2019) (1)
- Scintigraphic appearance of focal fatty infiltration of the liver using single-photon emission computed tomography (1984) (1)
- Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma: How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis? (2023) (1)
- Esophagus with multiple small Lugol's iodine-unstained lesions has high likelihood of developing multicentric esophageal squamous cell carcinoma (2003) (1)
- Su1172 CLINICAL UTILITY OF ENDOSCOPIC ULTRASOUND-GUIDED DRAINAGE USING CONTRAST-ENHANCED HARMONIC IMAGING IN CASES WITH DIFFICULTIES (2019) (1)
- 2.Local ablation therapy (2003) (1)
- Precut sphincterotomy from the pancreatic orifice using a standard papillotome (2004) (1)
- Molecular and Cellular Pathobiology p 38 a Inhibits Liver Fibrogenesis and Consequent Hepatocarcinogenesis by Curtailing Accumulation of Reactive Oxygen Species (2012) (1)
- Corrigendum to “Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging” [Eur. J. Radiol. 81 (7) (2012) 1460–1464] (2013) (1)
- Systemic Therapy for Hepatocellular Carcinoma: Recent Advances (2018) (1)
- How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases? (2022) (1)
- Utility of Gd-EOB-DTPA-Enhanced MRI in Diagnosing Small Hepatocellular Carcinoma (2009) (1)
- Chronic Liver Diseases and Liver Cancer: An Update in 2015: 12th Japan-Korea Liver Symposium (2015) (1)
- Real-world data in patients with hepatocellular carcinoma treated with transarterial chemoembolization: the second interim analysis of OPTIMIS (2018) (1)
- Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study (2023) (1)
- A novel teaching tool for visualizing the invisible bile duct axis in 3 dimensions during biliary cannulation (Compact Disc method) (2020) (1)
- Progression from early to advanced stage of immune‐related cholangitis (2022) (1)
- Abstract CT222: Pembrolizumab (pembro) for previously treated advanced hepatocellular carcinoma (aHCC): Meta-analysis of the phase 3 KEYNOTE-240 and KEYNOTE-394 studies (2022) (1)
- Sa1470 Does Endosonography-Guided Biliary Drainage Replace Percutaneous Transhepatic Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP? (2011) (1)
- Deep-learning framework based on a large ultrasound image database to realize computer-aided diagnosis for liver and breast tumors (2021) (1)
- Association of objective response by mRECIST with better overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with systemic therapies: A systematic review and meta-analysis of randomized controlled trials. (2020) (1)
- Endoscopic ultrasound-guided radiofrequency ablation of porcine liver (2020) (1)
- A bridge between multi-omics data and the management of hepatocellular carcinoma. (2015) (1)
- Harmonic Power Doppler and Other New Techniques on ALOKA ProSound Series (2003) (1)
- Endoscopic ultrasound‐guided biliary drainage with a 22‐gauge needle and a 0.018‐inch guidewire: Can it be the new standard? (2021) (1)
- 195OEfficacy and safety of nivolumab in asian patients with advanced hepatocellular carcinoma (HCC): Subanalysis of the CheckMate 040 Study (2017) (1)
- New Paradigm in Gastrointestinal Cancer Treatment (2017) (1)
- Endoscopic Ultrasound Fine-Needle Biopsy May Contribute to the Diagnosis of Malignant Lymph Nodes (2020) (1)
- Utility of contrast-enhanced harmonic endoscopic ultrasonography for diagnosis of pancreatic diseases (2011) (1)
- A CASE OF ESOPHAGEAL HEMANGIOMA EXCISED BY ENDOSCOPIC POLYPECTOMY (1986) (1)
- Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites. (2020) (1)
- How should radiation exposure be handled in fluoroscopy‐guided endoscopic procedures in the field of gastroenterology? (2021) (1)
- Can the Entire Ablative Hyperechoic Zone be Regarded as a Necrotic Lesion After Radiofrequency Ablation of the Liver? (2021) (1)
- Breakthroughs in hepatocellular carcinoma therapies. (2023) (1)
- [Basic and clinical evaluation of hepatobiliary function by 99mTc-pyridoxyl-5-methyl-tryptophan]. (1983) (1)
- Radiopharmaceutical preparation of technetium-99m-labeled galactosyl neoglycoalbumin. (1994) (1)
- Mo1380 Dynamic Imaging of Gallbladder Diseases by Contrast-Enhanced Harmonic EUS (2011) (1)
- Evaluation of shear wave dispersion caused by fibrous structure and tissue viscosity using hepatic fibrosis progression and histological models (2017) (1)
- Cases with Refractory Ascites and a Delayed Response to Tolvaptan (2016) (1)
- [Refractory idiopathic cold agglutinin disease successfully treated with intermittent high-dose cyclophosphamide]. (2001) (1)
- Reevaluation of Makuuchi’s criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey (2022) (1)
- A case with eosinophilic gastroenteritis exhibiting enhanced TNF-α and IL-6 responses (2021) (1)
- Revisionary antireflux metal stent placement for stent occlusion after endoscopic ultrasound-guided hepaticojejunostomy (2019) (1)
- Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC (2022) (1)
- Chronic Liver Diseases and Hepatocellular Carcinoma: An Update for 2013 (2013) (1)
- Well-differentiated hepatocellular carcinoma detected as hypovascularity by only CT during hepatic arteriography. (2012) (1)
- Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study (2022) (1)
- Response to the Letter to the Editor ‘Reply to “Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center Retrospective Study” by Dr. Peng Chen’ (2019) (1)
- [A case of suppurative pyelophlebitis with development of hepatoportal collaterals (cavernous transformation of the portal vein)]. (1985) (1)
- New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017 (2017) (1)
- Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials (2022) (1)
- Selection of Systemic Treatment Regimen for Unresectable Hepatocellular Carcinoma: Does Etiology Matter? (2022) (1)
- A randomized, double-blind, multicenter phase 3 study of brivanib versus placebo as adjuvant therapy to trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma: initial results (2013) (1)
- What is the best staging system for hepatocellular carcinoma? (2006) (1)
- Usefulness of the double-guidewire technique for endoscopic procedures in the field of biliary and pancreatic diseases (2022) (1)
- Achievement of cancer- and treatment-free status by atezolizumab plus bevacizumab combined with or without curative conversion in patients with transarterial chemoembolization-unsuitable, intermediate-stage hepatocellular carcinoma: A multicenter cohort study. (2023) (1)
- A phase 1b study of lenvatinib plus pembrolizumab in unresectable hepatocellular carcinoma (2020) (1)
- 169P IMbrave150: Management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC (2020) (1)
- [Small nodular lesions of the pancreas: differential diagnosis with ultrasound angiography]. (1994) (1)
- A novel method of papilla fixation for difficult biliary cannulation without using a pancreatic duct guidewire: non-guidewire fixation method (2021) (1)
- Mo1381 Role of EUS in Detection and Follow-Up of Intraductal Papillary Mucinous Neoplasms and Concomitant Invasive Carcinomas (2011) (1)
- Value of Low-Mechanical-Index Contrast-Enhanced Transabdominal Ultrasound for Diagnosis of Pancreatic Cancer: A Meta-analysis. (2021) (1)
- [Demonstration of PIVKA-II and AFP production by gastric cancer by indirect immunoenzymatic staining of paraffin sections]. (1991) (1)
- Agenesis of the left lobe of the liver: Radiologic findings (2001) (1)
- Progression patterns and therapeutic sequencing following immune checkpoint inhibition for HCC: an observational study (2022) (1)
- Hepatobiliary and pancreatic: Intrahepatic portal vein anomaly (2001) (1)
- MORPHOMETRICAL STUDY OF THE HUMAN LIVER WITH SPECIAL REFERENCE TO THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT TECHNIQUE (1998) (1)
- A novel and effective EUS training program that enables visualization of the learning curve: Educational Program of Kindai system (EPOK) (2022) (1)
- Response Evaluation Criteria in Cancer of the Liver (RECICL 2019 revised version) (2019) (1)
- 933P Updated results for pembrolizumab (pembro) monotherapy as first-line therapy for advanced hepatocellular carcinoma (HCC) in the phase II KEYNOTE-224 study (2021) (1)
- A unique profile of serum cytokines in type 1 autoimmune pancreatitis and chronic rhinosinusitis. (2021) (1)
- Case of Peutz‐Jeghers syndrome with depressed‐type early duodenal carcinoma (2012) (1)
- T1436: EUS-Guided Gallbladder Drainage for Treatment of Acute Cholecystitis and Obstructive Jaundice (2010) (1)
- Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab. (2022) (1)
- [Intravenous ultrasound contrast agent, Levovist]. (2001) (1)
- A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival. (2022) (1)
- EUS-guided drainage of the gallbladder using a novel 0.018-inch guidewire for preventing bile leakage (with video) (2022) (1)
- Author response to: Comment on: Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma (2020) (1)
- Multistep hepatocarcinogenesis : Correlation of imaging with pathology (2008) (1)
- Disruption of the intestinal barrier exacerbates experimental autoimmune pancreatitis by promoting the translocation of Staphylococcus sciuri into the pancreas. (2022) (1)
- 743TiPAN INTERNATIONAL OBSERVATIONAL STUDY TO ASSESS THE USE OF SORAFENIB AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): OPTIMIS. (2014) (1)
- Efficacy of endoscopic ultrasound-guided fine-needle aspiration for esophageal schwannoma (2021) (1)
- Mo1090 EXAMINATION OF ACTUAL RADIATION EXPOSURE DOSE OF THE PATIENTS WHO PERFORMED EUS-GUIDED DRAINAGE (EUS-BD/EUS-PD/EUS-CD) (2019) (1)
- Connected or disconnected: What's next after successful transmural drainage of pancreatic fluid collection? (2022) (1)
- Studies on the variation in clinical laboratory data and safety evaluation of pharmaceuticals. (2005) (1)
- Phase I/II Trial of Lenvatinib (E7080), A Multi-Targeted Tyrosine Kinase Inhibitor, in Patients (PTS) with advanced Hepatocellular Carcinoma (HCC) (2012) (1)
- Implications of the TACTICS Trial: Establishing the New Concept of Combination/Sequential Systemic Therapy and Transarterial Chemoembolization to Achieve Synergistic Effects (2022) (1)
- 17. Management of Hepatocellular Carcinoma: an Update (2018) (1)
- The Usefulness of Helicobacter pylori Eradication Therapy for the Healing of Artificial Gastric Ulcer After Endoscopic Submucosal Dissection for Early Gastric Cancer (2011) (1)
- Hepatobiliary and pancreatic: Inflammatory pseudotumor of the liver (2003) (1)
- Reply (2016) (1)
- Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus (2022) (1)
- A case of disseminated extrahepatic hepatocellular carcinoma after US-guided biopsy and percutaneous ethanol injection therapy. (2001) (1)
- Treatment of portal hypertension in patients with HCC at the era of Baveno VII. (2022) (1)
- Multicenter observational study of reactivation of hepatitis B virus (HBV) caused by chemotherapy for solid tumors (ST). (2014) (1)
- Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria (2022) (1)
- Su1168 LONG-TERM OUTCOMES OF EUS-GUIDED TRANSLUMINAL STENT DEPLOYEMNT FOR BENIGN BILIARY DISEASE: MULTICENTER CLINICAL EXPERIENCE (2019) (1)
- [Acute myeloid leukemia (FAB classification, M2) with translocation t(7;11) (p15;p15)]. (1987) (1)
- Proximal bifurcation of hepatic artery: Novel findings on hepatic arteries demonstrated by ultrasound Doppler imaging, B-flow, and US angiography (2002) (1)
- Long duration of stable disease may improve overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib (2012) (1)
- A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors (2022) (1)
- A New Type of Hypoglyeaemia in a Newborn Infant (1973) (1)
- Value of dynamic contrast enhanced MRI in predicting outcomes of HCC receiving radiotherapy (2015) (1)
- ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE FOR OBSTRUCTIVE JAUNDICE (2007) (1)
- Case Report: A Case of Intestinal Behçet's Disease Exhibiting Enhanced Expression of IL-6 and Forkhead Box P3 mRNA After Treatment With Infliximab (2021) (1)
- Tu1664 Quantitative Perfusion Analysis With Contrast-Enhanced Harmonic EUS in Pancreatic Tumors (2015) (1)
- Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2021) (1)
- Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL) (2022) (1)
- Tu1955 COMPUTER-AIDED DIAGNOSIS BASED ON CONVOLUTIONAL NEURAL NETWORK SYSTEM USING ARTIFICIAL INTELLIGENCE FOR COLORECTAL POLYP CLASSIFICATION (2019) (1)
- M1774 Evaluation of Liver Fibrosis in Diffuse Liver Disease Using Real-Time Tissue Elastography (2009) (1)
- The prognosis of patients with pancreatic cancer is extremely poor. Preface. (2011) (1)
- Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy (2019) (1)
- Spontaneous regurgitation of portal blood flow normalized by meal intake in a patient with alcoholic liver cirrhosis. (2003) (1)
- Erratum: First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study (International Journal of Clinical Practice (2012) 66 (675-683)) (2012) (1)
- Reply to the Letter to the editor 'Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus Sorafenib for advanced hepatocellular carcinoma: randomized phase II trial' by Fornaro et al. (2017) (1)
- Sa1664 The Clinical Characteristics and Endoscopic Treatment of Hemorrhagic Duodenal Varices (2013) (1)
- 932P IMbrave150: Exploratory efficacy and safety results in patients with hepatocellular carcinoma without macrovascular invasion (MVI) or extrahepatic spread (EHS) treated with atezolizumab (atezo) + bevacizumab (bev) or sorafenib (sor) (2021) (1)
- A case of cerebellar neuroectomesenchymoma in an infant. (1994) (1)
- Phase I study of sorafenib in combination with low-dose cisplatin and fluorouracil intra-arterial infusion chemotherapy. (2011) (1)
- Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy: 3rd International Kobe Liver Symposium on HCC with an International Liver Cancer Association (ILCA) Scientific Session, Hyogo, June 2009 (2010) (1)
- Tuesday, 28 August 2012 (2012) (1)
- 67O Outcomes in the Asian subgroup of the phase III HIMALAYA study of tremelimumab (T) plus durvalumab (D) in unresectable hepatocellular carcinoma (uHCC) (2022) (1)
- 68P A phase Ib study of lenvatinib + pembrolizumab (LEN + PEMBRO) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 116 follow-up analysis (2021) (1)
- Efficacy and safety of ramucirumab (RAM) in Asian and non-Asian patients with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Subgroup analysis from two randomized studies. (2018) (1)
- Randomized multicenter phase III trial of neoadjuvant gemcitabine + cisplatin + S-1 (GCS) versus surgery first for resectable biliary tract cancer (JCOG1920: NABICAT). (2023) (0)
- What is the best staging system for hepatocellular carcinoma? (2006) (0)
- Endoscopic submucosal dissection with reinforcement using a laparoscopic approach for a duodenal cavernous hemangioma (2022) (0)
- P-135 Pembrolizumab/quavonlimab coformulation in combination with lenvatinib in advanced hepatocellular carcinoma: Phase 2 trial in progress (2021) (0)
- Utility of endoscopic ultrasound in hemorrhage from recurrent duodenal varices (2018) (0)
- Validation and limitation of clip scoring system in 722 Japanese patients with HCC and a proposal of new prognostic system, Japan Integrated Staging score (JIS score) (2003) (0)
- Predictors of pain response in patients undergoing EUS-guided neurolysis for abdominal pain caused by pancreatic cancer (2016) (0)
- Front & Back Matter (2018) (0)
- [Molecular targeted agent for hepatocellular carcinoma]. (2012) (0)
- Usefulness of newly proposed albumin-bilirubin grade and its modification -Japan nationwide survey (2018) (0)
- Imaging Human Hepatocarcinogenesis (2004) (0)
- Application of Contrast-Enhanced Harmonic Imaging in Biliary and Pancreatic Tumors (2003) (0)
- High-fat diet aggravates experimental autoimmune pancreatitis through the activation of type I interferon signaling pathways. (2022) (0)
- Agent Detection Imaging (ADI) (Acuson Sequoia 512) (2003) (0)
- PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN (2018) (0)
- [Treatment of advanced hepatocellular carcinoma]. (2012) (0)
- Front & Back Matter (2018) (0)
- The Epoch Method of Defect Re-Purfusion Imaging to Diagnose Small Hepatocellular Carcinoma With New Second Contrast Agent Sonazoid (2013) (0)
- Evaluation of radionuclide scintigraphy, echography, and serum thyroglobulin in the diagnosis of thyroid nodules (1984) (0)
- Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2. (2020) (0)
- In Vivo Measurement of Hepatic Binding Protein Using Galactosyl-Neoglycoalbumin (1991) (0)
- Nontraumatic tube method for detecting a vessel responsible for colonic diverticular hemorrhage (2021) (0)
- Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm? (2021) (0)
- Non-invasive Diagnosis of Liver Clinical Condition by Real-time Tissue Elastography and Shear Wave Measurement : Get More Accessible by One Probe (2015) (0)
- Postvascular Phase Sweep Scan Using Liver-Specific Imaging (2003) (0)
- Front & Back Matter (2018) (0)
- Impact of viral aetiology in the Phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (uHCC) (2023) (0)
- C-Reactive Protein to Albumin Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Analysis (2021) (0)
- [Recent advances in EUS-guided biliary drainage]. (2013) (0)
- Contents Vol. 34, 2016 (2016) (0)
- P-80 Sorafenib in extended patient populations in real-world clinical practice: Baseline characteristics from OPTIMIS and GIDEON (2021) (0)
- 2079870 Quick and Easy Detection Method of Liver Tumor With New Technology for US (2015) (0)
- Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression. (2022) (0)
- Abstract No. 196: Worldwide trends in locoregional therapy (LRT) for hepatocellular carcinoma (HCC): 2nd interim analysis (IA; 1500 patients [pts]) of the GIDEON (global investigation of therapeutic decisions in HCC and of its treatment with sorafenib) study (2012) (0)
- Safety Report of a Phase II Trial of Irinotecan Plus S-1 (Iris) with Cetuximab in Pre-Treated Patients with KRAS Wild Type of Metastatic Colorectal Cancer: HGCSG0902 (2012) (0)
- Tislelizumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma: Impact on health-related quality of life in RATIONALE-301 population. (2023) (0)
- Tu1051 Noninvasive Assessment of Liver Fibrosis by Measurement of Lf Index in Patients With Chronic Viral Hepatitis (2013) (0)
- Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization (2019) (0)
- Intranodular Hemodynamic Transition Associated with Dedifferentiation of Hepatocellular Carcinoma (2003) (0)
- Sa1444 Therapeutic Strategies for Four Subtypes of Laterally Spreading Tumors of the Colorectum (2015) (0)
- •CLINICAL RESEARCH • Imaging findings of biliary hamartomas (2005) (0)
- Glossary of Harmonic Imaging Terms (2003) (0)
- Title Page / Table of Contents / Editorial Committee (2002) (0)
- Panel discussion: Management of hepatocellular carcinoma (2009) (0)
- REAL-TIME ARTIFICIAL INTELLIGENCE (AI) AUTOMATIC DIAGNOSTIC SYSTEM FOR COLORECTAL POLYPS USING RESIDUAL NETWORK (RESNET) (2022) (0)
- Subject Index Vol. 92, Suppl. 1, 2017 (2017) (0)
- US-US Overlay Fusion Imaging in the Evaluation of Treatment Response After RFA (2017) (0)
- Front & Back Matter (2021) (0)
- Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma (2023) (0)
- The Role of Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment of Hepatic Tumors (Summary) (2003) (0)
- Subject Index Vol. 78, Suppl. 1, 2010 (2010) (0)
- [Systemic therapy for hepatocellular carcinoma:recent advances and future perspective]. (2021) (0)
- Reply: HEPATOLOGY, Vol. XX, No. X, 2015 (2016) (0)
- P656 Clinical implications of endoscopic submucosal dissection in management of patients with ulcerative colitis-associated dysplasia (2020) (0)
- Case of endoscopic ultrasonography‐guided pancreatic duct rendezvous stenting in which initial contrast medium injection was useful for the second puncture (2018) (0)
- Safety and Effectiveness of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice: An Observational Post-Marketing Study in Japan (2023) (0)
- A Bridge to a Consensus on Hepatocellular Carcinoma Management: 2nd Asia Pacific Primary Liver Cancer Expert Meeting, Osaka, July 2011 (2011) (0)
- Comparison of Argon Plasma Coagulation and Paravariceal Injection Sclerotherapy of 1% Polidocanol in Mucosa-Fibrosing Therapy for Esophageal Varices (2004) (0)
- SHORT-SEGMENT BARRETT'S ESOPHAGUS AND BACKGROUND GASTRIC MUCOSA IN JAPANESE PATIENTS (2005) (0)
- CEUS for Pancreatobiliary Diseases (2017) (0)
- EARLY COMPLICATIONS FOLLOWING ENDOSCOPIC SPHINCTEROTOMY : CLINICAL FEATURES AND MANAGEMENT (1991) (0)
- Clinical Study of Prulifloxacin on Infectious Enteritis (1996) (0)
- Hepatobiliary and Pancreatic: Multiple pancreatic masses with rich vascularity (2022) (0)
- Welcome to the First Issue of Liver Cancer (2012) (0)
- Repeated hepatic arterial chemoembolization therapy for management of a patient with metastatic carcinoid tumors of the liver. (2000) (0)
- Transrectal endoscopic ultrasound-guided paracentesis for diagnosis of malignant ascites in the pelvis. (2017) (0)
- 624 STAKEHOLDER INVOLVEMENT IN PRIORITY SETTING OF STRATEGIES TO IMPROVE HEPATOCELLULAR CARCINOMA POLICY IN ASIA (2011) (0)
- 157PRandomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type mCRC: Japanese Skin Toxicity Evaluation Protocol with Panitumumab: J-STEPP/HGCSG1001: updated analysis of anti-tumor efficacy (2015) (0)
- Radiofrequency ablation therapy under contrast-enhanced harmonic imaging guidance for recurrence after local ablation therapy for hepatocellular carcinoma: A randomized controlled study (2003) (0)
- Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study. (2023) (0)
- Abstract 4185: Serum concentrations of angiogenesis-related molecules in patients with pancreatic cancer (2011) (0)
- Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician specialties. (2012) (0)
- Abstract 2296: Sorafenib inhibits hepatocyte growth factor-induced epithelial mesenchymal transition in hepatocellular carcinoma (2010) (0)
- Tailor-Made Therapy for Viral Hepatitis: 8th Japan-Korea Liver Symposium, Kobe, July 2011 (2011) (0)
- Mo2080 EUS-Guided Intrahepatic Biliary Drainage for Treatment of Obstructive Jaundice in Patients With Malignant Hilar Biliary Stricture After Ineffective or Unsuccessful Transpapillary Approach (2016) (0)
- Front & Back Matter (2017) (0)
- Contents Vol. 7, 2018 (2018) (0)
- Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼. (2018) (0)
- Subject Index Vol. 25, 2007 (2007) (0)
- CEUS in the Diagnosis and Treatment for Malignant Liver Tumors (2017) (0)
- Endosonography, Contrast Agents, and Elastography (2016) (0)
- [Effects of interferon treatment on recurrence and survival after curative treatment of hepatitis C virus-related hepatocellular carcinoma]. (2011) (0)
- Abstract 3402: Activin signal promotes cancer progression and is involved in cachexia in a subset of pancreatic cancer (2015) (0)
- A social program for the early diagnosis of pancreatic cancer (Kishiwada project): A pilot prospective multicenter study (2016) (0)
- Ischemic Enterocolitis Involving the Terminal Ileum and Sigmoid Colon: Report of a Case (1988) (0)
- Comparison between gradient and spin-echo (GRASE) and compressed sensing sequences for single breath-hold three-dimensional magnetic resonance cholangiopancreatography in patients with T1 hyperintense bile. (2022) (0)
- Pancreatic colonization of fungi in the development of severe acute pancreatitis (2022) (0)
- The usefulness of texture and color-enhanced imaging for balloon endoscopy-assisted ERCP for hepatic-jejunal anastomotic stenosis. (2022) (0)
- Letter to the EditorResponse (2005) (0)
- Radofrequency ablation (RFA) therapy under harmonic imaging guidance for the recurrence after local therapy for HCC: A randomized controlled study (2003) (0)
- Age and immunoglobulin G4‐associated autoimmune hepatitis: author's response (2010) (0)
- Front & Back Matter (2017) (0)
- 538PFIRST REPORT OF A PHASE II TRIAL OF IRINOTECAN PLUS S-1 (IRIS) WITH CETUXIMAB (IRIS/CET) IN PRE-TREATED PATIENTS WITH KRAS WILD TYPE OF METASTATIC COLORECTAL CANCER (MCRC): HGCSG0902. (2014) (0)
- Abstract CT120: Axitinib safety and pharmacokinetics in Child-Pugh A and Child-Pugh B patients with advanced hepatocellular cancer (2015) (0)
- 689 THE DECREASE OF BLOOD FLOW AFTER ADMINISTRATION OF SORAFENIB MAY IMPROVE OVERALL SURVIVAL IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (2012) (0)
- Su2036 The Decrease of Blood Flow After Administration of Sorafenib May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma (2012) (0)
- Validation and limitation of CLIP scoring system in 722 Japanese patients with hepatocellular carcinoma and a proposal of better prognostic staging system. Japan integrated staging score (JIS score) (2003) (0)
- Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis (2017) (0)
- Su1204 ENDOSCOPIC UTRASOUND-GUDED CHOLEDOCHODUODENOSTOMY USING A THIN STENT DELIVERY SYSTEM IN PATIENTS WITH UNRESECTABLE MALIGNANT DISTAL BILIARY OBSTRUCTION: A PROSPECTIVE MYLTICENTER STUDY (2019) (0)
- US-US overlay fusion in radiofrequency ablation therapy (RFA) for hepatocelluler carcinoma (2018) (0)
- Pembrolizumab (pembro) monotherapy for previously untreated advanced hepatocellular carcinoma (HCC): Phase 2 KEYNOTE-224 study. (0)
- A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort (2022) (0)
- Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel Disease (2019) (0)
- Can Localized Stenosis of the Main Pancreatic Duct be a Predictive Factor for Early Detection of Pancreatic Cancer? (2019) (0)
- Portal vein stenting for portal vein stenosis caused by bile duct cancer. (2017) (0)
- Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study (2022) (0)
- Background: Although the efficacy of combination therapy with lamivudine or tenofovir and pegylated interferon (PEG-IFN) has been reported in patients with chronic hepatitis B (CHB), the long-term effect of the combination based on the observation of clinical course (2018) (0)
- Relationship between overall survival and time to progression after transarterial chemoembolization therapy in patients with hepatocellular carcinoma (2017) (0)
- Papillary Neoplasm in a Common Channel in Patients with Pancreaticobiliary Maljunction (2018) (0)
- Objective Response by mRECIST is an Independent Prognostic Factor for overall Survival in Hepatocellular Carcinoma in SILIUS Trial (2019) (0)
- Subject Index Vol. 81, Suppl. 1, 2011 (2011) (0)
- Inclusion of Journal of Medical Ultrasonics in MEDLINE (2015) (0)
- 95P Additional survival follow-up of TACTICS-L: Transcatheter arterial chemoembolization therapy (TACE) in combination strategy with lenvatinib in (LEN) patients with unresectable hepatocellular carcinoma in Japan (2022) (0)
- Novel troubleshooting technique for the migration of a biliary plastic stent using a thin balloon catheter (with video) (2021) (0)
- GUIDELINES FOR CLINICAL PRACTICE Diagnosis of pancreatic tumors by endoscopic ultrasonography (2010) (0)
- A multicenter observational study of lenvatinib for unresectable hepatocellular carcinoma in Japan. (2021) (0)
- Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma (aHCC): 3-year follow-up of the phase 2 KEYNOTE-224 study. (2022) (0)
- Contents Vol. 25, 2007 (2007) (0)
- Integration of the Cancer-Related Pro-Inflammatory Response as a Stratifying Biomarker of Survival Benefit with Sorafenib in Hepatocellular Carcinoma (2016) (0)
- Role of ECL-cell histamine in acute gastric mucosal damage induced by ischemia-reperfusion (2001) (0)
- Mo1926 The Gross Classification of Hepatocellular Carcinoma: Usefulness of Contrast-Enhanced Sonography Using Perfluorocarbon Microbubbles (Sonazoid) (2012) (0)
- Viral Hepatitis and Hepatocellular Carcinoma: Update in 2012: 9th Korea-Japan Liver Symposium in Conjunction with the International Symposium of Asan Liver Center, Seoul, July 2012 (2012) (0)
- [Clinical studies on gastric juice secretion. Correlation between endoscopic and gastrocamera findings and gastric secretion]. (1965) (0)
- Sa1433 EUS-Guided Broad Plexus-Neurolysis Over the Superior Mesenteric Artery (2011) (0)
- Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study (2018) (0)
- Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2015): Evidence and Consensus on HCC Management 6th Meeting, Osaka, July 2015 (2015) (0)
- Front & Back Matter (2017) (0)
- Tu1363 HISTOLOGICAL DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMOR USING 25G FNA NEEDLE WITH CORE TRAP: MULTICENTER PROSPECTIVE STUDY (2019) (0)
- 1228 Stratification ability of the new prognostic staging system, Japan integrated staging score (JIS score) for hepatocellular carcinoma: comparison with clip score (2003) (0)
- differential diagnosis of small hcc focusing on pseudolymphoma and bile duct adenoma (2019) (0)
- EUS-guided drainage of the gallbladder using a novel 0.018-inch guidewire for preventing bile leakage (with video) (2022) (0)
- A prospective cohort study using a Japanese nationwide survey to evaluate the therapeutic effects of surgery and percutaneous ablation for hepatocellular carcinoma. (2012) (0)
- Image registration for RFA (2019) (0)
- Tu1927 Heat Shock Protein 27 Expression Is Inversely Correlated With Intraepithelial Neoplasia and Positively Correlated With Poor Differentiation of Gastric Cancer (2013) (0)
- Crohn's disease with gastroduodenal mucosa lesions that are similar to the lesions caused by ulcerative colitis. (2009) (0)
- Differential diagnosis of pancreatic diseases by contrast enhanced power doppler endosonography (2003) (0)
- 2396: Percutaneous radiofrequency ablation of liver tumors: Feasibility and usefulness of a novel guidance technique with an integrated system of CT and sonographic images (2006) (0)
- Pulse Inversion Harmonic Imaging (ATL HDI 5000) (2003) (0)
- Su1321 - Efficacy and Feasibility of Secondaly Prophylactic Pegfilgrastim in Patients with Pancreatic Cancer Recieving Modified Folfirinox: A Single Center Retrospective Study (2018) (0)
- PS-136-Can lenvatinib meet clinical needs of patients with unresectable hepatocellular carcinoma? Multicenter analysis (2019) (0)
- Information of APPLE 2017 (2017) (0)
- Front & Back Matter (2019) (0)
- Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the randomized, phase 3 KEYNOTE-240 study. (0)
- The Impact of Performance Status at Diagnosis on Progression-Free Survival After Second-Line Chemotherapy in Unfavorable-Risk Cancer of Unknown Primary Patients (2012) (0)
- Contents Vol. 35, 2017 (2017) (0)
- A resected case of stage IV hepatocellular carcinoma 5 years and 9 months after one shot arterial infusion chemotherapy. (1990) (0)
- [Is a liver scintigram necessary for diagnosis of hepatocellular carcinoma?]. (1987) (0)
- Subgroup analyses of a phase 1/2 study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC). (2017) (0)
- 1089: Treatment response and treatment guidance of hepatocellular carcinoma: Value of contrast-enhanced harmonic US and RVS (2006) (0)
- Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies (2019) (0)
- Contrast-Enhanced Harmonic Endoscopic Ultrasound-Guided Puncture for the Patients with Pancreatic Masses (2023) (0)
- Front & Back Matter (2017) (0)
- Immunohistochemical characterization of granulomatosis with polyangiitis exhibiting spontaneous regression. (2021) (0)
- IMbrave150: Exploratory analysis to examine the association between bevacizumab (bev) ever being skipped and bev never being skipped in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bev in a global phase 3 study. (2023) (0)
- Front & Back Matter (2019) (0)
- Hepatoma and medicine medical care. Medical treatment for the hepatoma. A treatment of the hepatoma by TAE. (1995) (0)
- Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience (2022) (0)
- Front & Back Matter (2019) (0)
- 556 COMPARISON OF DIAGNOSTIC CAPABILITY OF CONTRAST-ENHANCED CT, SONAZOID CONTRAST-ENHANCED US, GD-EOB-DTPA MRI AND CT ARTERIOPORTAL ANGIOGRAPHY IN DETECTING HISTOLOGICALLY PROVEN HCC NODULES SMALLER THAN 2CM (2010) (0)
- Contents Vol. 34, 2016 (2016) (0)
- Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials. (2021) (0)
- Prevention of Occurrence and Recurrence of Human Hepatocarcinogenesis (2005) (0)
- [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score]. (2004) (0)
- Reply: (2005) (0)
- Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response (2022) (0)
- What is CEUS LI-RADS? (2022) (0)
- An Objective Model to Optimize Treatment Decisions in Advanced Hepatocellular Carcinoma after Sorafenib Failure: The Sorfa Score (2016) (0)
- [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis]. (2018) (0)
- Clinical evaluation of angiotensin II perfused Tc-99m RBC imaging on hepatoma after transcatheter arterial embolization therapy (1984) (0)
- 2094 Randomized controlled trial on the skin toxicity of panitumumab in third line treatment of KRAS Exon2 wild-type metastatic colorectal cancer: HGCSG1001 (Japanese Skin Toxicity Evaluation Protocol With Panitumumab: J-STEPP): Updated analysis of anti-tumor efficacy (2015) (0)
- 723P Medical expenditures and treatment efficacy of patients who had initial hepatocellular carcinoma and underwent surgery or radiofrequency ablation: Accompanying research of the SURF trial (2022) (0)
- Su1307 Outcomes of Biliary Drainage in Pancreatic Cancer Patients With an Indwelling Gastroduodenal Stent: A Multicenter Retrospective Study in West Japan (2017) (0)
- Front & Back Matter (2018) (0)
- Contrast-enhanced Harmonic EUS Imaging of Pancreatic Mucinous Cystadenocarcinoma (2018) (0)
- Objective response (OR) by mRECIST to predict overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with sorafenib in the SILIUS trial. (2020) (0)
- Reply to Response to “‘A Case of Ulcerative Colitis Relapse Characterized by Systemic Type I Interferon Responses After COVID-19 Vaccination’” by Mungmunpuntipantip and Wiwanitkiton (2022) (0)
- Tu1483 - Hepatic Safety and Biomarker Assessments in Sorafenibexperienced Patients with Advanced Hepatocellular Carcinoma Treated with Nivolumab in the Checkmate-040 Study (2018) (0)
- Reintervention for stent occlusion after endoscopic ultrasound-guided hepatico-gastrostomy with novel use of a precut (2018) (0)
- JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B (2009) (0)
- Front & Back Matter (2019) (0)
- PHP107 Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC Bridge Study: An Interim Analysis of HCC Burden of Illness in the Asia-Pacific (AP) Cohort (2012) (0)
- 748 Stress Response Links Inflammation and Tumorigenesis in Inflammatory Bowel Disease (2015) (0)
- 153P Ramucirumab safety in East Asian (EA) compared to non-EA patients: A meta-analysis of adverse events (AEs) in 6 global, randomized, double-blind, phase 3 clinical trials (2016) (0)
- 73MO Regorafenib in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world practice in Asia: Final analysis of the prospective, observational REFINE study (2022) (0)
- Sa1317 NEW METHOD FOR DIFFICULT BILIARY CANNULATION USING THE NOVEL UNEVEN DOUBLE LUMEN CANNULA (DLC METHOD) (2018) (0)
- O2-8-1Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Japanese subgroup analysis of the phase III REACH trial (2015) (0)
- Signals Triggering Proliferation of Hepatocellular Carcinoma (2014) (0)
- Case of adult genotype C HBV carrier after acute hepatitis B, losing HBsAg and acquiring HBsAb after IFN and lamivudine treatment. (2006) (0)
- Predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review (2023) (0)
- Subject Index Vol. 51, Suppl. 1, 2008 (2008) (0)
- [Current status of biliary drainage for acute cholangitis]. (2022) (0)
- Mo1369 Utility of EUS-Guided Gallbladder Drainage for Rescue Treatment of Malignant Biliary Obstruction (2014) (0)
- 172PUpdated analysis: observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin (OX) + BV and oral FU/OX + BV (2015) (0)
- How should a therapeutic strategy be constructed for acute cholecystitis after self-expanding metal stent placement for malignant biliary obstruction? (2022) (0)
- Abstract 3371: Expression levels of EMT-related genes in hepatocellular carcinoma (2011) (0)
- 1041 SIMILAR EFFICACY AND SAFETY OF ENDOSCOPIC ULTRASOUND-GUIDED BILIARY DRAINAGE VIA HEPATICOGASTROSTOMY AND CHOLEDOCHODUODENOSTOMY APPROACHES FOR MALIGNANT DISTAL BILIARY OBSTRUCTION: A MULTICENTER, PROSPECTIVE, RANDOMIZED TRIAL (2018) (0)
- Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma (2022) (0)
- 1089P Hepcidin expression as a predictive biomarker for anti-PD1/PDL1 antibody monotherapy for advanced non-small cell lung cancer (2022) (0)
- Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma. (2022) (0)
- Evidence and topics of chemotherapy for hepatocellular carcinoma. (2017) (0)
- Radiofrequency ablation therapy for hepatocellular carcinoma located at subphrenic region: Value of artificial pleural effusion combined with contrast-Harmonic imaging (2003) (0)
- [Prevention of recurrence of liver cancer]. (2008) (0)
- Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients. (2023) (0)
- Evaluation of shear wave dispersion caused by fibrous structure and tissue viscosity using hepatic fibrosis progression and histological models (2017) (0)
- Characterization of tumor responses in patients (pts) with unresectable hepatocellular carcinoma (uHCC) treated with lenvatinib in REFLECT. (2022) (0)
- Efficacy and Safety of Elbasvir/Grazoprevir Combination Therapy for Chronic Hepatitis C (2019) (0)
- Abstract No. 210 KEYNOTE-937 trial in progress: adjuvant pembrolizumab for hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation (2021) (0)
- WS1. the expansion of surgical indication in gastric colorectal cancer drug therapy (2012) (0)
- Molecular Targeted Therapy for Hepatocellular Carcinoma: Bench to Bedside: 7th Japan-Korea Liver Symposium, Kyoto, July 2010 (2011) (0)
- Sa1648 Percutaneous Endoscopic Gastrostomy With Gastropexy Greatly Reduces the Risk of Peristomal Infection and Eases Pain After the Operation (2012) (0)
- A New Horizon in Liver Disease (2016) (0)
- 2092 Updated analysis: Observational cohort study of 1st line bevacizumab combined with chemotherapy in metastatic colorectal cancer (HGCSG0802): Comparison of infusional FU/oxaliplatin(OX)+BV and oral FU/OX+BV (2015) (0)
- New diagnostic method for hepatic steatosis using attenuation measurement by B mode ultrasound: Comparison with controlled attenuation parameter (2018) (0)
- EUS-guided interventions for walled-off pancreatic necrosis: Clinical outcomes of a step-up approach and risk factors for failed endoscopic treatment (2016) (0)
- Early diagnosis of pancreatic cancer by EUS (2017) (0)
- Liver Transplantation, Liver Cancer and Tumor Markers in Asian Countries: 2nd Awaji Liver Symposium and 3rd Japan-Korea Liver Symposium, Awaji, Hyogo, November 2006 (2007) (0)
- Vascularity and Hemodynamics of Liver Tumors as Seen with Intraarterial Contrast-Enhanced Ultrasonography (2003) (0)
- Pancreatic Cancer: Hot Topics in 2011 (2011) (0)
- Relation of tumor vascularity to effect of gemcitabine in pancreatic carcinomas: Value of contrast-enhanced harmonic ultrasonography. (2006) (0)
- OS1. gastric cancer (2012) (0)
- AFP is elevated more than 10 years before hepatocellular carcinoma development is detected: this observation leads to a practical risk stratification strategy (2020) (0)
- Dissemination of clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists and liver surgeons (2007) (0)
- RELATIVITY-106: A phase 1/2 trial of nivolumab (NIVO) + relatlimab (RELA) in combination with bevacizumab (BEV) in first-line (1L) hepatocellular carcinoma (HCC). (2023) (0)
- Endoscopic ultrasonography‐guided gallbladder drainage procedures: Is the glass half‐full or half‐empty? (2014) (0)
- PancreatitisHuman IgG4-Related Autoimmune of Murine Autoimmune Pancreatitis and Production Are Prominent Features a IFN-Plasmacytoid Dendritic Cell Activation and (2015) (0)
- Nivolumab Versus Sorafenib Treatment in Advanced Hepatocellular Carcinoma (CheckMate 459): A Randomised, Multicentre, Open-Label, Phase 3 Trial (2021) (0)
- Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity (2023) (0)
- P0383 : Combined sequential use of HAP and ART scores to predict transarterial chemoembolization failure in hepatocellular carcinoma: A multi-center comparative study (2015) (0)
- The APPLE Association President's Message (2017) (0)
- Emerging Strategies to Hepatocellular Carcinoma: 4th International Kyoto Liver Cancer Symposium, Kyoto, June 2014: Invited Reviews and Symposium Abstracts (2014) (0)
- 687 PROGNOSIS OF RUPTURED HEPATOCELLULAR CARCINOMA: IMPACT ON TUMOR STAGING SYSTEM BASED ON A NATIONWIDE SURVEY (2012) (0)
- Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer (2014) (0)
- Regorafenib vs. cabozantinib as second-line treatment for advanced hepatocellular carcinoma: an anchored matching-adjusted indirect comparison of efficacy and safety (2022) (0)
- Activation of NOD1 and NOD2 in the development of liver injury and cancer (2022) (0)
- Comparative Pharmacokinetic Behavior of Levovist with Water-Soluble Contrast Agents (2003) (0)
- Lenvatinib as an Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond up-to-seven Criteria and Child-Pugh A Liver Function: A Proof-of-Concept Study (2019) (0)
- Title Cold-inducible RNA-binding protein promotes thedevelopment of liver cancer (2018) (0)
- A case of psoriasis vulgaris complicated with antimitochondrial M2 antibody-positive liver dysfunction after infliximab treatment (2015) (0)
- Practice patterns, radiologic tumor response, and deterioration of liver function after transarterial chemoembolization (TACE): Final analysis of OPTIMIS in Korea and other regions. (2018) (0)
- A New Horizon in Liver Disease: 5th International Kyoto Liver Symposium (IKLS), Kyoto, May 2016: Proceedings (2017) (0)
- [Imaging diagnosis of hepatocellular carcinoma: recent progress]. (2001) (0)
- Su1381 EUS-Guided Gallbladder Drainage As an Alternative Treatment for Malignant Biliary Obstruction After Unsuccessful ERCP: Outcomes of Long Term Follow-Up (2011) (0)
- Front & Back Matter (2019) (0)
- Su1681 Removal of Diminutive Colorectal Polyps: A Prospective Randomized Comparative Study between Cold Snare Polypectomy (CSP) and Hot Biopsy Forceps (HBF) (2016) (0)
- [Efficacy of adjuvant treatment after curative treatment in patients with HBV related hepatocellular carcinoma]. (2011) (0)
- Mo1291 Investigation on the Efficacy of Alteration of Treatment Methods for Difficult Cases in Eus-Bd (2017) (0)
- Front & Back Matter (2020) (0)
- Staging system for hepatocellular carcinoma-it concept and clinical impact- (2005) (0)
- ENDOSCOPIC FINDINGS OF SEVERE ULCERATIVE COLITIS (1983) (0)
- A case of HCC successfully treated with infliximab‐steroid sequential therapy for small bowel perforation due to atezolizumab/bevacizumab combination therapy (2022) (0)
- Tu1351 Prospective Randomized Controlled Study of Helicobacter pylori Eradication in Japan (2016) (0)
- Coded Harmonic Angio (GE LOGIQ 700 EXPERT Series) (2003) (0)
- Searching for biological markers of molecular targeting treatment of liver cancer. (2010) (0)
- ‘Reply to “Clinical Safety and Efficacy of Secondary Prophylactic Pegylated G-CSF in Advanced Pancreatic Cancer Patients Treated with mFOLFIRINOX: A Single-center (2019) (0)
- Updated Analysis: Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients with Metastatic Colorectal Cancer: Hokkaido Gastrointestinal Cancer Study Group (HGCSG) Trial (2012) (0)
- 2 IgG 4-Related Disease ( IgG 4-RD ) and Microbe-Associated Molecular Patterns ( MAMPs ) and Damage-Associated Molecular Patterns ( DAMPs ) 2 . 1 MAMPs and DAMPs (2016) (0)
- OR-HPB-04: The role of endoscopic ultrasonography in diagnosis and treatment of autoimmune pancreatitis (2017) (0)
- Feasibility and efficacy of endoscopic reintervention after covered metal stent placement for EUS-guided hepaticogastrostomy: A multicenter experience (2022) (0)
- Preface (2011) (0)
- 85P Safety and efficacy of atezolizumab (Atezo) + bevacizumab (Bev) in Japanese patients (pts) with unresectable hepatocellular carcinoma (uHCC): A prospective, multicenter, observational study (ELIXIR) - A preliminary analysis (2022) (0)
- Front & Back Matter (2021) (0)
- Liver tumor detection and classification from abdominal ultrasound images with CenterNet using contrastive learning (2023) (0)
- SO-13 Pembrolizumab in patients with advanced hepatocellular carcinoma (aHCC) previously treated with sorafenib: Updated data from the open-label, phase 2 KEYNOTE-224 study (2022) (0)
- Vascularity of gastric carcinoma: evaluation using color Doppler ultrasonography (2005) (0)
- Disruption of TGF-β Pathway and Epithelial-Mesenchymal Transition Phenotype (2015) (0)
- Application of artificial intelligence in medical imaging and AI-aided US diagnosis (2020) (0)
- Management of Hepatocellular Carcinoma - New Insights and Future Prospects: 6th Asia-Pacific Primary Liver Cancer Expert Meeting, Osaka, July 2015: Proceedings (2015) (0)
- Impact of vitamin K dosing during sorafenib treatment for hepatocellular carcinoma: Effect on ischemic tumor cell damage caused by sorafenib. (2016) (0)
- Value of EUS and follow-up studies in IPMN cases for early diagnosis of pancreatic cancer (2016) (0)
- Author's response to reviews Title: A novel biomarker TERTmRNA is applicable for early detection of hepatoma Authors: (2009) (0)
- Comparison of Radiation Exposure between Endoscopic Ultrasound-Guided Hepaticogastrostomy and Hepaticogastrostomy with Antegrade Stenting (2022) (0)
- Abstract No. 117 A phase 3, double-blind, randomized study of nivolumab and Ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma (2021) (0)
- Relationship of atezolizumab plus bevacizumab treatment with muscle volume loss in unresectable hepatocellular carcinoma patients– multicenter analysis (2022) (0)
- [Tumor vascularity in small hepatocellular carcinoma]. (1990) (0)
- Phase II Trial of Combined Chemotherapy with Irinotecan, S-1, and Bevacizumab (IRIS/BEV) In Patients with Metastatic Colorectal Cancer -Updated Analysis-. Hokkaido Gastrointestinal Cancer Study Group (HGCSG) Trial (2012) (0)
- non b non c related hepatocellular carcinoma with sarcomatous change due to epithelial mesenchymal transition (2019) (0)
- P551 EVALUATION OF ART SCORE FOR REPEATED TRANSARTERIAL CHEMOEMBOLIZATION IN JAPANESE COHORT OF HEPATOCELLULAR CARCINOMA (2014) (0)
- Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma (2021) (0)
- multiple hnf 1 inactivated type hepatocellular adenoma due to intrahepatic portosystemic venous shunt (2019) (0)
- T1948 Evaluation of the Effectiveness of Radiofrequency Ablation for Hepatic Malignancies: Usefulness of Virtual CT Sonography Using Magnetic Navigation (2008) (0)
- 727TiP A randomised phase III study of tremelimumab (T) plus durvalumab (D) with or without lenvatinib combined with concurrent transarterial chemoembolisation (TACE) versus TACE alone in patients (pts) with locoregional hepatocellular carcinoma (HCC): EMERALD-3 (2022) (0)
- O3-13-4Global GIDEON data: Subgroup analysis of sorafenib dosing pattern in patients with unresectable hepatocellular carcinoma (2016) (0)
- Impact of bodyweight (BW)-based starting doses on safety and efficacy of lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC). (2021) (0)
- [Management of hepatocellular carcinoma: current status and future perspective]. (2023) (0)
- 67P Real-world data for atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma (2022) (0)
- Hepatocellular Carcinoma 2009 and Beyond: 5th Japan-Korea Liver Symposium, Osaka, August 2008 (2008) (0)
- Detection of recurring lesion of hepatocellular carcinoma after radiofrequency ablation therapy using Levovist enhanced second harmonic power Doppler/B mode imaging (2000) (0)
- Imaging Diagnosis of various HCC subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence (2022) (0)
- Global phase III study of tislelizumab versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma (HCC): A trial-in-progress. (2018) (0)
- Treatment of advanced hepatocellular carcinoma: Future perspective. (2017) (0)
- Principles of Harmonic Imaging (2003) (0)
- What is the most appropriate diagnostic strategy for evaluating a small common bile duct stone? (2022) (0)
- Gastrointestinal: Intrathoracic upside-down stomach. Commentary (2001) (0)
- Su1680 Follow-Up Examination of the Recurrence After Endoscopic Treatment of Colorectal Tumors (2017) (0)
- New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017: 14th Japan-Korea Liver Symposium, Hiroshima, June 2017 (2017) (0)
- F6-7 Imaging for a sialoglycoprotein receptor: Functional evaluation (1995) (0)
- Subject Index Vol. 11, Suppl. 2, 2011 (2011) (0)
- [TAE therapy of hepatocellular carcinoma]. (1995) (0)
- Subject Index Vol. 75, Suppl. 1, 2008 (2008) (0)
- Usefulness and limitatin of contrast-enhanced power Doppler EUS for diagnosis of pancreatic diseases (2006) (0)
- Subject Index Vol. 72, Suppl. 1, 2007 (2007) (0)
- A Multicenter Prospective Validation Study on Selective Endoscopic Resection of Sessile Serrated Lesions Using Magnifying Colonoscopy in Clinical Practice. (2023) (0)
- 1232 Validation study of the new prognostic staging system, for hepatocellular carcinoma in 3,934 Japanese patients: a multicenter collaborative study (2003) (0)
- [Effects of isosorbide dinitrate on Oddi's sphincter]. (1992) (0)
- Emerging Strategies for the Management of Hepatocellular Carcinoma: 4th International Kyoto Liver Cancer Symposium (4th IKLS), Kyoto, June 2014 (2014) (0)
- P77 L1CAM is an independent predictor of poor survival of endometrial cancer undergoing full lymphadenectomy and adjuvant chemotherapy (2019) (0)
- Changes of lens culinaris agglutinin-reactive alpha-fetoprotein (AFP-L3 fraction) after complete radiofrequency ablation for hepatocellular carcinoma (2003) (0)
- Molecular and Cellular Pathobiology Stress Response Protein Cirp Links In fl ammation and Tumorigenesis in Colitis-Associated Cancer (2014) (0)
- [Stomach-duodenal ulcer and gastric juice--significiance and value of the gastric juice examination]. (1966) (0)
- Health-related quality of life (HRQoL) impact of lenvatinib (len) plus pembrolizumab (pembro) versus len plus placebo (pbo) as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC): Phase 3 LEAP-002 study. (2023) (0)
- Refractory post-band ligation bleeding misdiagnosed as esophageal varix rupture caused by primary biliary cirrhosis: A case report (2021) (0)
- Liver Cancer in Japan - State of the Art: Top Articles of the 50th Annual Meeting of the Liver Cancer Study Group of Japan, Kyoto, June 2014 (2014) (0)
- Tu1349 LINEAR EUS TRAINING BY USING SYSTEMATIC SCREENING PROTCOL FOR THE PANCREATOBILIARY SYSTEM (2019) (0)
- 4th International Kyoto Liver Cancer Symposium: Emerging Strategies to HCC. Kyoto, Japan, June 7–8, 2014: Abstracts (2014) (0)
- Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study. (2021) (0)
- Requirement of Additional Surgery after Non-Curative Endoscopic Submucosal Dissection for Early Colorectal Cancer (2020) (0)
- Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms (2014) (0)
- Endoscopic papillotomy and papilloplasty: Effects on sphincter of Oddi functionality and outcomes (2021) (0)
- A case with Crohn's disease-associated spondyloarthritis exhibiting enhanced pro-inflammatory cytokine responses to Toll-like receptor ligands. (2021) (0)
- An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib. (2020) (0)
- Sa1941 Verrucous Antral Gastritis Is Not Related to H. pylori-Positive Chronic Gastritis, but Is Related to a High BMI and Barrett's Esophagus (2013) (0)
- Usefulness of anisotropic diffusion method in cerebral perfusion study using multi-detector row CT (2005) (0)
- Hepatocellular carcinoma: recent development of molecular targeted agent (The 49th annual meeting of Japanese Society of Clinical Oncology educational book) -- (JSCO University: Hepato-biliary and pancreas cancers) (2011) (0)
- Contents Vol. 32, 2014 (2014) (0)
- Hepatobiliary and pancreatic: Fatty liver, spared areas and aberrant gastric venous drainage (2003) (0)
- The APPLE Association President's Message (2019) (0)
- Su1580 EUS-Guided Drainage for Treatment of Postoperative Complications After Pancreatic Surgery (2013) (0)
- NOD2 deficiency protects mice from the development of adoptive transfer colitis through the induction of regulatory T cells expressing forkhead box P3. (2021) (0)
- Front & Back Matter (2020) (0)
- Application of contrast-enhanced ultrasonography to the local treatment of hepatocellular carcinoma (2002) (0)
- Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study (2021) (0)
- Usefulness of contrast-enhanced coded phase-inversion harmonic ultrasonography for differential diagnosis of pancreatic diseases and evaluation of chemotherapy (2003) (0)
- Artificial intelligence models for the diagnosis and management of liver diseases (2022) (0)
- FRI-503-Sorafenib starting dose impacts on survival in the elderly population with hepatocellular cancer (2019) (0)
- Initial lenvatinib therapy with no prior TACE in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria and Child-Pugh A liver function: A proof-of-concept study. (2020) (0)
- Advances in Immunotherapy for Hepatocellular Carcinoma (2023) (0)
- Hepatocellular Carcinoma and the Role of Blood Flow Imaging in Clinical Practice (2003) (0)
- Prognostic subclassification of Intermediate Hepatocellular Carcinoma (I-HCC): a multicentre cohort study with propensity score analysis. (2015) (0)
- FORTHCOMING ARTICLES MARCH 2010 (2009) (0)
- 2096 Phase II trial of Irinotecan plus S-1 (IRIS) with Cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type of metastatic colorectal cancer (mCRC): HGCSG0902 updated analysis (2015) (0)
- Cross‐wired metal stents for endoscopic bilateral stent‐in‐stent deployment in malignant hilar biliary obstruction: A multicenter, single‐arm, prospective study (2021) (0)
- Asia-Pacific Primary Liver Cancer Expert Meeting / Liver Cancer Study Group of Japan: 3rd Asia-Pacific Primary Liver Cancer Expert Meeting, Shanghai, July 2012 / Liver Cancer Study Group of Japan, 48th Annual Meeting, Kanazawa, July 2012 (2013) (0)
- Treatment Response andTolerability in Elderly Patientswith Chronic Hepatitis C:Subgroup Analysis in ReGIT-JStudy (2014) (0)
- Acute Megakaryocytic Leukemia Associated with Primary Mediastinal Germ Cell Tumor: A Case Report (2012) (0)
- Risk-stratified management of advanced hepatocellular carcinoma (HCC) (2018) (0)
- Involvement of innate immunity in chronic fibro-inflammatory responses of the pancreas (2018) (0)
- 248 Comparison of staging systems for hepatocellular carcinoma in a japanese cohort (2006) (0)
- Sa1422 THE USEFULNESS OF NOVEL CANNULATION METHOD USING A UNIQUE, DOUBLE LUMENS CATHETER (UNEVEN METHOD) FOR THE PATIENTS WITH SURGICALLY ALTERED GASTROINTESTINAL ANATOMY (2019) (0)
- Differential Diagnosis of Various Hepatic Tumors by Harmonic Imaging (2003) (0)
- T1950 Contrast Enhanced Sonography for Hepatic Malignancies: Value of Defect RE-Injection Test (2008) (0)
- Immunohistochemical classification of localized amyloidosis by light and immunoelectron microscopy (1990) (0)
- Sa1437 A MULTICENTER SINGLE-ARM PROSPECTIVE STUDY TO ASSESS THE UTILITY AND SAFTY OF NOVEL FULLY COVERED METAL STENT FOR OBSTRUCTIVE JAUNDICE IN PATIENTS WITH UNRESECTABLE DISTAL MALIGNANT BILLIARY OBSTRUCTION (2019) (0)
- Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]. (2019) (0)
- The “straighten pigtail” technique for selective replacement of a pigtail plastic stent (2022) (0)
- Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC: The ABE Index (2023) (0)
- Contrast Imaging (Toshiba PowerVision 8000 and Aplio) (2003) (0)
- Do Endoscopic Ultrasound-Guided Transluminal Procedures Involve High Radiation Exposure? (2020) (0)
- Hepatocellular carcinoma Therapeutic response assessment of RFA for HCC : Contrast-enhanced US , CT and MRI (2014) (0)
- Reply to Kadayifci and Brugge (2014) (0)
- Tu1648 PROGNOSTIC IMPACT OF TYROSINE KINASE INHIBITOR SEQUENTIAL TREATMENT INCLUDING LENVATINIB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA (2020) (0)
- 2312: Evaluation of liver function by contrast enhanced coded phase inversion harmonic ultrasonography with levovist using parenchymal imaging of liver and spleen in the post vascular phase (2006) (0)
- 0410: Image Analysis of Real-time Tissue Elastography for Evaluation of Liver Fibrosis Progression (2009) (0)
- P-269Phase II trial of Irinotecan/S-1 (IRIS) with Cetuximab (IRIS/Cet) as second line treatment in patients with KRAS WT metastatic colorectal cancer: HGCSG0902. -Comparison of administration interval in Cetuximab treatment (2015) (0)
- [Efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel]. (2004) (0)
- New Paradigm in Gastrointestinal Cancer Treatment: 1st Kindai International Symposium on Gastrointestinal Cancer (KISGIC), Osaka-Sayama, July 2017: Proceedings (2018) (0)
- Real world data of systemic therapy for hepatocellular carcinoma in Japan: HERITAGE study. (2023) (0)
- The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid (2020) (0)
- Thanking All Peer Reviewers. (2019) (0)
- Ulcerative Colitis-associated Spondyloarthritis Successfully Treated with Infliximab in the Absence of Enhanced TNF-α Responses. (2022) (0)
- Assessment of Hepatobilliary Phase Gd-EOB-DTPA-Enhanced MRI for HCC and Borderline Lesions and Comparison of Detection Ability Versus MDCT (2011) (0)
- Alterations of autophagic and innate immune responses by the Crohn’s disease-associated ATG16L1 mutation (2022) (0)
- 295 Novel Association Between Global DNA Hypomethylation and Chromosomal Instability Phenotype in Human Hepatocellular Carcinoma (2012) (0)
- A Mouse Model of Acute and Chronic Pancreatitis (2022) (0)
- The APPLE Association President's Message (2017) (0)
- Detection of recurring lesion of hepatocellular carcinoma after therapy using Levovist enhanced second harmonic power Doppler/B mode imaging (2000) (0)
- PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
- The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma (2023) (0)
- Atypical focal spared area in fatty liver: evaluation by color Doppler ultrasonography (2004) (0)
- A case of transcatheter arterial embolization for intraperitoneal hemorrhage due to giant hepatic segmental arterial mediolysis. (2023) (0)
- Contents Vol. 33, 2015 (2015) (0)
- Reply (2016) (0)
- [Hepatocellular carcinoma]. (2011) (0)
- Evaluation of image quality of personal ultrasound imager: Comparison with the conventional machine (2002) (0)
- The optimal dose period of indisetron tablets for preventing chemotherapy-induced nausea and vomiting (CINV) induced by mFOLFOX6: An exploratory trial HGCSG0703. (2011) (0)
- Front & Back Matter (2019) (0)
- Clinical Application of Contrast-Enhanced Harmonic Imaging to Endosonography (2007) (0)
- Efficacy and safety of tislelizumab, an anti-PD-1 antibody, versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma in a phase 3, randomized, open-label, multicenter study - Trial in progress. (2018) (0)
- 109 GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPS (2012) (0)
- 06-07-09 EVALUATION OF LIVER FIBROSIS IN DIFFUSE LIVER DISEASE USING REAL-TIME TISSUE ELASTOGRAPHY (2009) (0)
- 380 SUPERIORITY OF CT ARTERIOPORTAL ANGIOGRAPHY TO CONTRAST-ENHANCED CT AND MRI IN THE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA IN NODULES SMALLER THAN 2CM (2008) (0)
- Title Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study (2016) (0)
- Tu1384 VALUE OF THE BISPECTRAL INDEX MONITOR DURING ENDOSCOPIC ULTRASONOGRAPHY UNDER SEDATION WITH PROPOFOL AND MIDAZOLAM (2019) (0)
- Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma (2019) (0)
- Su1214 Activation of JNK in the Non-Cancerous Liver Tissue Predicts a High Risk of Recurrence After Hepatic Resection for Hepatocellular Carcinoma (2012) (0)
- Blood flow and disease state of hepatoma. Advance and significance of the ultrasonic wave blood flow image. (1998) (0)
- 1240 Comparison of posttreatment prognosis between ablation and resection for early-stage hepatocellular carcinoma: standardized analysis of 737 patients by stratification method based on JIS scoring system (2003) (0)
- The Utility of Endoscopic Ultrasonography Using 30 MHz, 20 MHz and 12 MHz Endoscopic Ultrasoundprobe, Endoscopy in the Endoscopic Submucosaldesection of Early Gastric Cancer (2005) (0)
- [Current topics on therapy of hepatocellular carcinoma]. (2005) (0)
- O2-14-1Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study (2017) (0)
- Dendritic Cells and IL-33 Produced by Plasmacytoid α Autoimmune Pancreatitis Depend on IFN-Chronic Fibro-Inflammatory Responses in Masatoshi (2017) (0)
- 377TiPPhase 3, randomized KEYNOTE-240 study of pembrolizumab (Pembro) versus best supportive care (BSC) for second-line advanced hepatocellular carcinoma (HCC) (2017) (0)
- Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma (2023) (0)
- Revisions of the clinical practice guidelines for hepatocellular carcinoma in 2021 version (2023) (0)
- Special Remarks on HCC Treatment (2012) (0)
- The “echo-free space” technique: a safe and reliable method for endoscopic ultrasound scope insertion (2023) (0)
- 04d. Molecular and Cellular Biology (d) Liver Regeneration and Experimental Oncology I@bullet Peginterferon Alpha-2a and 5-fluorouracil Suppresses Proliferation of Human Hepatocelllar Carcinoma in P53-mediated Apoptotic Response [@bullet Involvement of Poly(adp-ribose) Polymerase-1 (parp-1) in the D (0)
- The APPLE Association President's Message (2019) (0)
- The Roles of Contrast-Enhanced Harmonic Imaging in Treating Hepatocellular Carcinoma (2003) (0)
- A Case of Waldenstrom Macroglobulinemia with Temporary Appearance of 7S IgM Half Molecule. (2017) (0)
- Successful initial tofacitinib treatment for acute severe ulcerative colitis with steroid resistance: a case series (2022) (0)
- Real-world data in 1000 patients with unresectable hepatocellular carcinoma (HCC) treated with systemic therapy: Patient background in PRISM study. (2023) (0)
- Pancreatic neuroendocrine carcinoma with unique morphological features mimicking intraductal papillary mucinous carcinoma: A case report (2022) (0)
- Recent Progress in Hepatocellular Carcinoma 2007: 90-year Anniversary Issue of Katsusaburo Yamagiwa's Innovative Achievement on Carcinogenesis (2008) (0)
- Cronkhite-Canada Syndrome Mimicking COVID-19-related Symptoms (2022) (0)
- Closing Remarks (2012) (0)
- Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease (2023) (0)
- Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 Trial (2023) (0)
- P3–105RANDOMIZED STUDY TO EXPLORE INDISETRON FOR THE PREVENTION OF ACUTE-ONSET DIARRHEA, NAUSEA, VOMITING WITH IRIS/FOLFIRI (2013) (0)
- T2071 Clinicopathological Time Trends for Early Gastric Cancer and Helicobacter pylori Infection in Japan (2008) (0)
- Update and Direction of Ultrasonic Contrast Agents (2003) (0)
- Front & Back Matter (2012) (0)
- Gideon (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [SOR]) 2nd Interim Analysis (IA): Subgroup Analysis by Disease Etiology (2012) (0)
- Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma (2023) (0)
- Albumin-Bilirubin Grade Analyses of Atezolizumab Plus Bevacizumab vs Sorafenib in Patients With Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study (2023) (0)
- 162PUpdated analysis: Phase II trial of irinotecan plus S-1 (IRIS) with cetuximab (IRIS/Cet) in pre-treated patients with KRAS wild type metastatic colorectal cancer (mCRC): HGCSG0902 (2015) (0)
- Abstract 2145: Genomic and transcriptomic analyses related to the clinical efficacy of first-line nivolumab in advanced hepatocellular carcinoma from the phase 3 CheckMate 459 trial (2022) (0)
- Sa1515 Detection of Small Concomitant Carcinomas Distinct From Intraductal Papillary Mucinous Neoplasms Under Surveillance of the Whole Pancreas Using EUS (2012) (0)
- Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors (2023) (0)
- Abstract No. 241: Worldwide trends in locoregional therapy for hepatocellular carcinoma (HCC): First interim analysis of the global investigation of therapeutic decisions in HCC and of its treatment with sorafenib (GIDEON) study (2011) (0)
- Chronic Liver Diseases and Hepatocellular Carcinoma: Update in 2013: 10th Korea-Japan Liver Symposium, Busan, July 2013 (2013) (0)
- Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev). (2023) (0)
- [A case of gastrointestinal stromal tumor (GIST) in the stomach]. (2000) (0)
- [New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol]. (1989) (0)
- Case Report: Regulatory T Cell-Independent Induction of Remission in a Patient With Collagenous Colitis (2021) (0)
- 257 Low-dose, long-term interferon alfa 2B delays clinical recurrence after curative radiofrequency ablation in patients with hepatitis C related hepatocellular carcinoma (2004) (0)
- Abstract No. 37 LEAP-012 trial in progress: pembrolizumab, lenvatinib, and transarterial chemoembolization combination therapy for intermediate-stage hepatocellular carcinoma not amenable to curative treatment (2021) (0)
- Tu1668 Contrast-Enhanced Harmonic Endoscopic Ultrasonography for Diagnosing Cystic Tumors in the Pancreas (2015) (0)
- Contrast-Enhanced Harmonic EUS of Intra-Abdominal Lesions with Undetermined Origin: Initial Observation of Vascularity Depiction (2009) (0)
- Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1 / PD-L 1 and Anti-CTLA-4 Antibodies (2019) (0)
- S1640 Combination Therapy of Ecabet Sodium and Proton Pump Inhibitor (PPI) Compared with PPI Alone for Endoscopic Submucosal Dissection (ESD) -Induced Ulcer in Gastric Cancer: Prospective Randomized Study (2008) (0)
- 461 Carcinogenic risk factors in hepatitis B virus infection (2006) (0)
- Mo1928 Usefullness of Contrast-Enhanced Ultrasonography to Evaluate a Post Treatment Effect of Radiofrequentry Ablation About Hepatocellular Carcinoma; Comparion With Contrast-Enhanced CT (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Masatoshi Kudo?
Masatoshi Kudo is affiliated with the following schools:
